| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.87e-16 | 14 | 158 | 9 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 7.18e-14 | 23 | 158 | 9 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 8.45e-13 | 29 | 158 | 9 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 8.45e-13 | 29 | 158 | 9 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 4.28e-12 | 34 | 158 | 9 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.52e-10 | 49 | 158 | 9 | GO:0051861 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.91e-10 | 70 | 158 | 10 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.93e-10 | 73 | 158 | 10 | GO:0170055 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 ADCY8 PIK3R1 SKAP1 PSG8 LILRB5 | 1.33e-09 | 210 | 158 | 14 | GO:0019903 |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 1.75e-09 | 28 | 158 | 7 | GO:0005251 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PTPRF PIK3R1 PSG8 | 2.47e-09 | 149 | 158 | 12 | GO:1990782 |
| GeneOntologyMolecularFunction | phosphatase binding | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 ADCY8 PIK3R1 SKAP1 PSG8 LILRB5 | 2.49e-08 | 264 | 158 | 14 | GO:0019902 |
| GeneOntologyMolecularFunction | calmodulin binding | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 ADCY8 ADD2 PIK3R1 SCN2A PSG8 | 3.79e-08 | 230 | 158 | 13 | GO:0005516 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 3.95e-08 | 90 | 158 | 9 | GO:0008028 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.22e-06 | 173 | 158 | 10 | GO:0070851 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP5ME CACNA1F PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 TRPC6 PEX13 CHRNB3 PIEZO2 KCNA1 SLC8B1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A TMC8 PSG8 STRA6 | 1.93e-06 | 1180 | 158 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 ADCY8 ADD2 TENM4 TENM3 PIK3R1 PSG8 | 3.54e-06 | 398 | 158 | 14 | GO:0046982 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | ATP5ME CACNA1F TRPC6 CHRNB3 PIEZO2 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A | 3.57e-06 | 343 | 158 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.75e-06 | 196 | 158 | 10 | GO:0005319 | |
| GeneOntologyMolecularFunction | protein kinase binding | FLNA PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PPP1R12A PFKFB2 LYST ADD2 PTPN5 KCNA5 PTPRF PIK3R1 SKAP1 PSG8 EMP2 | 5.57e-06 | 873 | 158 | 21 | GO:0019901 |
| GeneOntologyMolecularFunction | actin binding | FLNA KLHL1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 TRPC6 ADCY8 ADD2 CYFIP1 PSG8 | 6.42e-06 | 479 | 158 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 8.29e-06 | 17 | 158 | 4 | GO:0099508 | |
| GeneOntologyMolecularFunction | transporter activity | ATP5ME CACNA1F PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 TRPC6 PEX13 CHRNB3 PIEZO2 KCNA1 SLC8B1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A TMC8 PSG8 STRA6 | 9.47e-06 | 1289 | 158 | 26 | GO:0005215 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1F CHRNB3 PIEZO2 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A TMC8 | 1.46e-05 | 334 | 158 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.49e-05 | 182 | 158 | 9 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.63e-05 | 184 | 158 | 9 | GO:0022832 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 1.67e-05 | 102 | 158 | 7 | GO:0005249 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ATP5ME CACNA1F TRPC6 CHRNB3 PIEZO2 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A TMC8 | 1.78e-05 | 459 | 158 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNA FN1 LILRB2 NLGN3 FASN TENM4 PTPRD PTPRF TENM3 PTPRM EMP2 LTBP4 CDH6 LILRB5 CDH11 CDH18 | 2.26e-05 | 599 | 158 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | kinase binding | FLNA PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PPP1R12A PFKFB2 LYST ADD2 PTPN5 KCNA5 PTPRF PIK3R1 SKAP1 PSG8 EMP2 | 2.67e-05 | 969 | 158 | 21 | GO:0019900 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.88e-05 | 152 | 158 | 8 | GO:0022843 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.11e-05 | 207 | 158 | 9 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.27e-05 | 208 | 158 | 9 | GO:0005342 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | ARHGAP32 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PLEKHA5 PSG8 | 4.47e-05 | 316 | 158 | 11 | GO:0035091 |
| GeneOntologyMolecularFunction | potassium channel activity | 7.21e-05 | 128 | 158 | 7 | GO:0005267 | |
| GeneOntologyMolecularFunction | channel activity | ATP5ME CACNA1F TRPC6 CHRNB3 PIEZO2 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A TMC8 | 7.63e-05 | 525 | 158 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | IgM binding | 7.66e-05 | 11 | 158 | 3 | GO:0001791 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ATP5ME CACNA1F TRPC6 CHRNB3 PIEZO2 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A TMC8 | 7.79e-05 | 526 | 158 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | protein homodimerization activity | FLNA PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 TRPC6 ADCY8 ADD2 SLC8B1 TENM4 TENM3 PSG8 LILRB5 | 8.25e-05 | 815 | 158 | 18 | GO:0042803 |
| GeneOntologyMolecularFunction | phosphatase activity | PPP1R12A PFKFB2 PTPN5 PTPN13 PTPRD PTPRF PTPRM SYNJ2 PTPRQ LPIN2 | 9.92e-05 | 287 | 158 | 10 | GO:0016791 |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 1.01e-04 | 12 | 158 | 3 | GO:0032396 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.70e-04 | 103 | 158 | 6 | GO:0004725 | |
| GeneOntologyMolecularFunction | polyamine oxidase activity | 1.86e-04 | 3 | 158 | 2 | GO:0046592 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | PPP1R12A PFKFB2 PTPN5 PTPN13 PTPRD PTPRF PTPRM SYNJ2 PTPRQ LPIN2 SMPD1 | 2.60e-04 | 386 | 158 | 11 | GO:0042578 |
| GeneOntologyMolecularFunction | cytokine receptor binding | 2.65e-04 | 324 | 158 | 10 | GO:0005126 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 3.05e-04 | 17 | 158 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 3.05e-04 | 17 | 158 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 3.63e-04 | 18 | 158 | 3 | GO:0032393 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor | 3.69e-04 | 4 | 158 | 2 | GO:0016647 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.74e-04 | 167 | 158 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | protein dimerization activity | FLNA PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 TRPC6 ASCL3 CLOCK ADCY8 ADD2 SLC8B1 TENM4 TENM3 PIK3R1 PSG8 LILRB5 | 5.48e-04 | 1205 | 158 | 21 | GO:0046983 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 5.56e-04 | 293 | 158 | 9 | GO:0008514 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 6.13e-04 | 5 | 158 | 2 | GO:0030107 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 7.81e-04 | 189 | 158 | 7 | GO:0004721 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP5ME CACNA1F TRPC6 CHRNB3 PIEZO2 KCNA1 SLC8B1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A | 8.26e-04 | 664 | 158 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 9.14e-04 | 6 | 158 | 2 | GO:0030109 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 9.14e-04 | 6 | 158 | 2 | GO:1905030 | |
| GeneOntologyMolecularFunction | transcription factor binding | ZNF703 FLNA USP11 HIPK2 CLOCK GSC PAXBP1 CIITA PIK3R1 PRDM13 NCOA7 BSN FEM1A RBFOX2 FOXC1 | 9.59e-04 | 753 | 158 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.11e-03 | 26 | 158 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1F TRPC6 KCNA1 SLC8B1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A | 1.21e-03 | 465 | 158 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 1.24e-03 | 27 | 158 | 3 | GO:0015271 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 1.27e-03 | 7 | 158 | 2 | GO:0023025 | |
| GeneOntologyMolecularFunction | phospholipid binding | ARHGAP32 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 FAAH PLEKHA5 PSG8 | 1.42e-03 | 548 | 158 | 12 | GO:0005543 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP5ME CACNA1F TRPC6 CHRNB3 PIEZO2 KCNA1 SLC8B1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A TMC8 | 1.60e-03 | 793 | 158 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | PPP1R12A PFKFB2 FAAH PTPN5 FASN PTPN13 PTPRD PTPRF AARS2 PTPRM SYNJ2 PTPRQ LPIN2 SMPD1 ZC3H12C | 1.90e-03 | 807 | 158 | 15 | GO:0016788 |
| GeneOntologyMolecularFunction | immune receptor activity | 2.03e-03 | 165 | 158 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | threonine-type endopeptidase activity | 2.16e-03 | 9 | 158 | 2 | GO:0004298 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 2.87e-03 | 36 | 158 | 3 | GO:0019865 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 3.27e-03 | 11 | 158 | 2 | GO:0016303 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 4.16e-03 | 41 | 158 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 4.16e-03 | 41 | 158 | 3 | GO:0023023 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP5ME CACNA1F TRPC6 KCNA1 SLC8B1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A | 4.25e-03 | 627 | 158 | 12 | GO:0022890 |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulatory subunit binding | 5.32e-03 | 14 | 158 | 2 | GO:0036312 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNA KLHL1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 TRPC6 ADCY8 ADD2 CYFIP1 KCNA2 KCNA5 PSG8 | 6.30e-03 | 1099 | 158 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 6.94e-03 | 16 | 158 | 2 | GO:0016641 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 6.94e-03 | 16 | 158 | 2 | GO:0023029 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase regulator activity | 6.94e-03 | 16 | 158 | 2 | GO:0046935 | |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 7.67e-03 | 51 | 158 | 3 | GO:0001784 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 8.09e-03 | 52 | 158 | 3 | GO:0042169 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 PIK3R1 PSG8 LTF LILRB5 LILRA4 | 1.32e-17 | 59 | 158 | 14 | GO:0045671 |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.16e-17 | 18 | 158 | 10 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.40e-16 | 14 | 158 | 9 | GO:0070348 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.71e-16 | 21 | 158 | 10 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.71e-16 | 21 | 158 | 10 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.47e-16 | 15 | 158 | 9 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.47e-16 | 15 | 158 | 9 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 3.47e-16 | 15 | 158 | 9 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.47e-16 | 15 | 158 | 9 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 7.88e-16 | 16 | 158 | 9 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.66e-15 | 17 | 158 | 9 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.66e-15 | 17 | 158 | 9 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.66e-15 | 17 | 158 | 9 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 PIK3R1 PSG8 LTF LILRB5 LILRA4 | 3.17e-15 | 85 | 158 | 14 | GO:0002762 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DSC3 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 FAT3 PTPRF HMCN1 TENM3 PTPRM PSG8 CDH6 CDH11 CDH18 | 5.34e-15 | 187 | 158 | 18 | GO:0007156 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 6.08e-15 | 28 | 158 | 10 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 9.22e-15 | 29 | 158 | 10 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.13e-14 | 20 | 158 | 9 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.96e-14 | 21 | 158 | 9 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 3.30e-14 | 22 | 158 | 9 | GO:0030853 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSC3 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 FAT3 SLITRK2 TENM4 PTPRD PTPRF HMCN1 TENM3 PTPRM PSG8 CDH6 CDH11 CDH18 | 3.62e-14 | 313 | 158 | 21 | GO:0098742 |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 5.38e-14 | 23 | 158 | 9 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.38e-14 | 23 | 158 | 9 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 8.55e-14 | 24 | 158 | 9 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 8.55e-14 | 24 | 158 | 9 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 8.55e-14 | 24 | 158 | 9 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.33e-13 | 25 | 158 | 9 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.33e-13 | 25 | 158 | 9 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 PIK3R1 PSG8 LTF LILRB5 LILRA4 | 2.76e-13 | 116 | 158 | 14 | GO:0045670 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 3.01e-13 | 27 | 158 | 9 | GO:0070344 | |
| GeneOntologyBiologicalProcess | cell junction organization | ZNF703 FLNA FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 CNTNAP1 ADD2 NLGN3 SLITRK2 PTPN13 CYFIP1 TENM4 PTPRD PTPRF TENM3 PIK3R1 RBMX PRICKLE2 PKHD1 PSG8 BSN PATJ CAPRIN1 CDH6 CDH11 CDH18 | 4.09e-13 | 974 | 158 | 33 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.26e-12 | 31 | 158 | 9 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.74e-12 | 32 | 158 | 9 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.74e-12 | 32 | 158 | 9 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.74e-12 | 32 | 158 | 9 | GO:0060312 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 SBNO2 PIK3R1 PSG8 LTF LILRB5 LILRA4 | 1.94e-12 | 162 | 158 | 15 | GO:0030316 |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell differentiation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 PIK3R1 PSG8 LTF LILRB5 LILRA4 | 2.07e-12 | 134 | 158 | 14 | GO:0045638 |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.38e-12 | 33 | 158 | 9 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 2.38e-12 | 33 | 158 | 9 | GO:2000252 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | FLNA PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PSG8 FOXC1 FOXC2 | 2.89e-12 | 87 | 158 | 12 | GO:0001974 |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 3.21e-12 | 34 | 158 | 9 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 3.21e-12 | 34 | 158 | 9 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 3.32e-12 | 49 | 158 | 10 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 4.12e-12 | 50 | 158 | 10 | GO:0002834 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 4.30e-12 | 35 | 158 | 9 | GO:1901142 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | ZNF703 FLNA PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CNTNAP1 PKHD1 PSG8 PATJ CDH6 CDH11 CDH18 | 7.08e-12 | 246 | 158 | 17 | GO:0045216 |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 7.67e-12 | 53 | 158 | 10 | GO:0034110 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 9.73e-12 | 38 | 158 | 9 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 PIK3R1 PSG8 LTF LILRB5 LILRA4 | 1.07e-11 | 151 | 158 | 14 | GO:1902106 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.26e-11 | 39 | 158 | 9 | GO:0045717 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.37e-11 | 56 | 158 | 10 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.61e-11 | 40 | 158 | 9 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 2.05e-11 | 41 | 158 | 9 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 PIK3R1 PSG8 LTF LILRB5 LILRA4 | 2.16e-11 | 159 | 158 | 14 | GO:1903707 |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 2.59e-11 | 42 | 158 | 9 | GO:0090330 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.83e-11 | 60 | 158 | 10 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 LILRB2 PSG8 IL4I1 | 3.55e-11 | 107 | 158 | 12 | GO:0042130 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 3.77e-11 | 83 | 158 | 11 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 5.05e-11 | 45 | 158 | 9 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 6.24e-11 | 46 | 158 | 9 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 6.24e-11 | 46 | 158 | 9 | GO:0072574 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 7.62e-11 | 66 | 158 | 10 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 7.67e-11 | 47 | 158 | 9 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 7.67e-11 | 47 | 158 | 9 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 7.67e-11 | 47 | 158 | 9 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 8.90e-11 | 67 | 158 | 10 | GO:0045601 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.14e-10 | 49 | 158 | 9 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 PIK3R1 PSG8 LTF LILRB5 LILRA4 | 1.33e-10 | 182 | 158 | 14 | GO:0002761 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ZNF703 FLNA DSC3 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 LILRB2 FAT3 ADD2 NLGN3 SLITRK2 TENM4 PTPRD PTPRF HMCN1 TENM3 PTPRM PIK3R1 SKAP1 PKHD1 PSG8 IL4I1 CDH6 CDH11 CDH18 | 1.46e-10 | 1077 | 158 | 31 | GO:0098609 |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.61e-10 | 71 | 158 | 10 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.89e-10 | 96 | 158 | 11 | GO:0002704 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 2.00e-10 | 52 | 158 | 9 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 LILRB2 PSG8 IL4I1 | 2.04e-10 | 124 | 158 | 12 | GO:0050672 |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 LILRB2 PSG8 IL4I1 | 2.46e-10 | 126 | 158 | 12 | GO:0032945 |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PIK3R3 CYFIP1 PTPRF PIK3R1 LPIN2 PSG8 SORL1 FOXC2 | 3.14e-10 | 271 | 158 | 16 | GO:0032869 |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 5.03e-10 | 105 | 158 | 11 | GO:0042267 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 LILRB2 PSG8 IL4I1 | 5.05e-10 | 134 | 158 | 12 | GO:0070664 |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 7.55e-10 | 109 | 158 | 11 | GO:0002228 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 7.65e-10 | 60 | 158 | 9 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 8.91e-10 | 61 | 158 | 9 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 1.12e-09 | 86 | 158 | 10 | GO:0042058 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte differentiation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 SBNO2 FASN PIK3R1 PSG8 LTF LILRB5 LILRA4 | 2.43e-09 | 312 | 158 | 16 | GO:0002573 |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 2.45e-09 | 93 | 158 | 10 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 2.76e-09 | 69 | 158 | 9 | GO:0030195 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 3.02e-09 | 124 | 158 | 11 | GO:0034109 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 3.02e-09 | 95 | 158 | 10 | GO:0070527 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 3.15e-09 | 70 | 158 | 9 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 3.15e-09 | 70 | 158 | 9 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 3.59e-09 | 71 | 158 | 9 | GO:0043114 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 4.07e-09 | 72 | 158 | 9 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 4.07e-09 | 72 | 158 | 9 | GO:0032692 | |
| GeneOntologyBiologicalProcess | regulation of cell development | ARHGAP32 FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 LILRB2 PPP1R12A TRPC6 CLOCK CYFIP1 TENM4 PTPRD PTPRF PIK3R1 PSG8 LTF MAP2K2 IL4I1 CAPRIN1 LILRB5 RBFOX2 LILRA4 SORL1 | 4.21e-09 | 1095 | 158 | 29 | GO:0060284 |
| GeneOntologyBiologicalProcess | regulation of behavior | 4.23e-09 | 128 | 158 | 11 | GO:0050795 | |
| GeneOntologyBiologicalProcess | feeding behavior | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PEX13 GALR2 PSG8 STRA6 | 4.48e-09 | 162 | 158 | 12 | GO:0007631 |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 4.61e-09 | 73 | 158 | 9 | GO:0042304 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PIK3R3 ADCY8 CYFIP1 PTPRF PIK3R1 LPIN2 PSG8 SORL1 FOXC2 | 6.10e-09 | 381 | 158 | 17 | GO:0071375 |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 PIK3R1 PSG8 LTF LILRB5 RBFOX2 LILRA4 | 6.39e-09 | 288 | 158 | 15 | GO:0045637 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 6.64e-09 | 76 | 158 | 9 | GO:0042269 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 LILRB2 PSG8 IL4I1 | 8.27e-09 | 171 | 158 | 12 | GO:0050868 |
| GeneOntologyBiologicalProcess | response to insulin | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PIK3R3 CYFIP1 PTPRF PIK3R1 LPIN2 PSG8 SORL1 FOXC2 | 9.00e-09 | 342 | 158 | 16 | GO:0032868 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 6.60e-16 | 16 | 157 | 9 | GO:0070021 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1F FLNA PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 LILRB2 CHRNB3 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A SKAP1 PSG8 PATJ FXYD2 CDH6 LILRB5 CDH11 CDH18 LILRA4 | 1.60e-13 | 785 | 157 | 30 | GO:0098797 |
| GeneOntologyCellularComponent | cell-cell junction | FLNA DSC3 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 TRPC6 CNTNAP1 KCNA2 KCNA5 HMCN1 PTPRM PIK3R1 SCN2A SKAP1 PSG8 PATJ MAP2K2 CDH6 CDH11 CDH18 | 2.41e-12 | 591 | 157 | 25 | GO:0005911 |
| GeneOntologyCellularComponent | adherens junction | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 HMCN1 PTPRM PSG8 CDH6 CDH11 CDH18 | 7.72e-10 | 212 | 157 | 14 | GO:0005912 |
| GeneOntologyCellularComponent | anchoring junction | FLNA DSC3 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PPP1R12A TRPC6 CNTNAP1 CYFIP1 KCNA1 KCNA2 KCNA5 HMCN1 PTPRM PIK3R1 SCN2A SKAP1 PSG8 PATJ MAP2K2 CDH6 CDH11 CDH18 | 9.03e-10 | 976 | 157 | 28 | GO:0070161 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.46e-09 | 90 | 157 | 10 | GO:0016328 | |
| GeneOntologyCellularComponent | membrane protein complex | ATP5ME CACNA1F FLNA PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 LILRB2 PIK3R3 TRPC6 CHRNB3 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 PIK3R1 SCN2A SKAP1 PSG8 PATJ FXYD2 CDH6 LILRB5 CDH11 CDH18 LILRA4 | 4.76e-09 | 1498 | 157 | 34 | GO:0098796 |
| GeneOntologyCellularComponent | glutamatergic synapse | FLNA PRSS12 CNTNAP1 PI4K2A ADCY8 FAAH ADD2 NLGN3 SLITRK2 KCNA1 KCNA2 KCNA3 TENM4 KCNA4 PTPRD TENM3 RBMX SCN2A PRICKLE2 PLEKHA5 BSN CAPRIN1 CDH6 CDH11 | 1.07e-08 | 817 | 157 | 24 | GO:0098978 |
| GeneOntologyCellularComponent | ciliary membrane | 5.37e-08 | 98 | 157 | 9 | GO:0060170 | |
| GeneOntologyCellularComponent | apical plasma membrane | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 ADCY8 KCNA1 KCNA5 PTPRQ PKHD1 PSG8 EMP2 PATJ | 1.62e-07 | 487 | 157 | 17 | GO:0016324 |
| GeneOntologyCellularComponent | T cell receptor complex | 4.41e-07 | 163 | 157 | 10 | GO:0042101 | |
| GeneOntologyCellularComponent | cell surface | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 HLA-DQA1 PSG9 PSG11 LILRB2 CR1L NLGN3 MELTF KCNA1 KCNA4 KCNA5 CIITA PKHD1 PSG8 LTF EMP2 BSN LILRB5 SORL1 | 8.38e-07 | 1111 | 157 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PIK3R3 RPAP1 PIK3R1 POLR1B PSG8 | 1.56e-06 | 335 | 157 | 13 | GO:0061695 |
| GeneOntologyCellularComponent | cation channel complex | ATP5ME CACNA1F TRPC6 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A | 1.70e-06 | 235 | 157 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | apical part of cell | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 ADCY8 KCNA1 KCNA5 PTPRQ PKHD1 PSG8 EMP2 PATJ | 2.40e-06 | 592 | 157 | 17 | GO:0045177 |
| GeneOntologyCellularComponent | basal plasma membrane | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CR1L ADCY8 PTPRQ PSG8 FXYD2 | 2.87e-06 | 354 | 157 | 13 | GO:0009925 |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.96e-06 | 157 | 157 | 9 | GO:1902554 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 5.62e-06 | 91 | 157 | 7 | GO:0008076 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CR1L ADCY8 PSG8 FXYD2 | 5.66e-06 | 320 | 157 | 12 | GO:0016323 |
| GeneOntologyCellularComponent | protein kinase complex | 5.69e-06 | 170 | 157 | 9 | GO:1902911 | |
| GeneOntologyCellularComponent | basal part of cell | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CR1L ADCY8 PTPRQ PSG8 FXYD2 | 5.85e-06 | 378 | 157 | 13 | GO:0045178 |
| GeneOntologyCellularComponent | receptor complex | FLNA PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 ITLN1 PSG11 ITLN2 CR1L CHRNB3 SKAP1 PTPRQ PSG8 | 8.18e-06 | 581 | 157 | 16 | GO:0043235 |
| GeneOntologyCellularComponent | potassium channel complex | 1.36e-05 | 104 | 157 | 7 | GO:0034705 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | FLNA PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CHRNB3 SKAP1 PSG8 | 1.39e-05 | 350 | 157 | 12 | GO:0098802 |
| GeneOntologyCellularComponent | membrane raft | ITLN1 ASAH2 PI4K2A ITLN2 CR1L ADCY8 ADD2 KCNA3 KCNA5 SYNJ2 SKAP1 EMP2 | 1.95e-05 | 362 | 157 | 12 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | ITLN1 ASAH2 PI4K2A ITLN2 CR1L ADCY8 ADD2 KCNA3 KCNA5 SYNJ2 SKAP1 EMP2 | 2.05e-05 | 364 | 157 | 12 | GO:0098857 |
| GeneOntologyCellularComponent | cell projection membrane | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 ITLN1 PSG11 ITLN2 KCNA2 SYNJ2 PSG8 | 2.35e-05 | 431 | 157 | 13 | GO:0031253 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | ATP5ME CACNA1F TRPC6 CHRNB3 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A | 2.97e-05 | 378 | 157 | 12 | GO:0034702 |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 3.38e-05 | 9 | 157 | 3 | GO:0032998 | |
| GeneOntologyCellularComponent | synaptic membrane | PI4K2A ADCY8 CHRNB3 PTPN5 NLGN3 SLITRK2 KCNA1 KCNA2 KCNA3 KCNA4 PTPRD PTPRF TENM3 SCN2A BSN | 3.49e-05 | 583 | 157 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | external side of plasma membrane | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 LILRB2 CR1L PKHD1 PSG8 LILRB5 | 3.87e-05 | 519 | 157 | 14 | GO:0009897 |
| GeneOntologyCellularComponent | axon initial segment | 6.28e-05 | 29 | 157 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | transporter complex | ATP5ME CACNA1F TRPC6 PEX13 CHRNB3 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A FXYD2 | 7.21e-05 | 550 | 157 | 14 | GO:1990351 |
| GeneOntologyCellularComponent | dendrite | FLNA ARHGAP32 KLHL1 PRSS12 FAT3 PI4K2A ADCY8 PTPN5 NLGN3 SLITRK2 CYFIP1 KCNA1 KCNA2 KCNA4 SACS BSN CAPRIN1 EPHA10 | 8.19e-05 | 858 | 157 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | FLNA ARHGAP32 KLHL1 PRSS12 FAT3 PI4K2A ADCY8 PTPN5 NLGN3 SLITRK2 CYFIP1 KCNA1 KCNA2 KCNA4 SACS BSN CAPRIN1 EPHA10 | 8.43e-05 | 860 | 157 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | Fc receptor complex | 8.70e-05 | 12 | 157 | 3 | GO:0032997 | |
| GeneOntologyCellularComponent | side of membrane | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 ITLN1 PSG11 LILRB2 ITLN2 CR1L MELTF PKHD1 PSG8 MAP2K2 LILRB5 | 1.05e-04 | 875 | 157 | 18 | GO:0098552 |
| GeneOntologyCellularComponent | presynapse | PRSS12 CNTNAP1 PI4K2A ADCY8 CHRNB3 PTPN5 NLGN3 CYFIP1 KCNA1 KCNA2 KCNA3 KCNA4 PTPRD KCNA6 TENM3 SYNJ2 SCN2A BSN | 1.23e-04 | 886 | 157 | 18 | GO:0098793 |
| GeneOntologyCellularComponent | plasma membrane raft | 1.25e-04 | 147 | 157 | 7 | GO:0044853 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1F FLNA ARHGAP32 KLHL1 PRSS12 FAT3 PI4K2A ADCY8 PTPN5 NLGN3 SLITRK2 CYFIP1 KCNA1 KCNA2 KCNA4 PTPRF SACS NRSN1 BSN CAPRIN1 EPHA10 SORL1 | 1.31e-04 | 1228 | 157 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | axon | FLNA PRSS12 CNTNAP1 ADCY8 PTPN5 CYFIP1 KCNA1 KCNA2 KCNA3 KCNA4 KCNA6 PTPRF TENM3 SACS SYNJ2 SCN2A NRSN1 BSN | 1.31e-04 | 891 | 157 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | transmembrane transporter complex | ATP5ME CACNA1F TRPC6 CHRNB3 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A FXYD2 | 1.66e-04 | 523 | 157 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | presynaptic membrane | 2.54e-04 | 277 | 157 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | paranode region of axon | 2.62e-04 | 17 | 157 | 3 | GO:0033270 | |
| GeneOntologyCellularComponent | supraspliceosomal complex | 3.33e-04 | 4 | 157 | 2 | GO:0044530 | |
| GeneOntologyCellularComponent | neuron projection terminus | 3.89e-04 | 233 | 157 | 8 | GO:0044306 | |
| GeneOntologyCellularComponent | cilium | DRC7 CACNA1F DNAH3 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 EFHB GALR2 DNAH14 PKHD1 PSG8 IL4I1 | 4.32e-04 | 898 | 157 | 17 | GO:0005929 |
| GeneOntologyCellularComponent | spermatoproteasome complex | 5.52e-04 | 5 | 157 | 2 | GO:1990111 | |
| GeneOntologyCellularComponent | main axon | 5.60e-04 | 89 | 157 | 5 | GO:0044304 | |
| GeneOntologyCellularComponent | postsynapse | FLNA ARHGAP32 ADCY8 CHRNB3 ADD2 NLGN3 SLITRK2 CYFIP1 KCNA1 KCNA2 KCNA3 KCNA4 PTPRF RBMX PRICKLE2 PLEKHA5 BSN CAPRIN1 | 6.52e-04 | 1018 | 157 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | axon terminus | 1.07e-03 | 210 | 157 | 7 | GO:0043679 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.29e-03 | 107 | 157 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | distal axon | FLNA PRSS12 CYFIP1 KCNA1 KCNA2 KCNA3 KCNA6 PTPRF SYNJ2 NRSN1 | 1.70e-03 | 435 | 157 | 10 | GO:0150034 |
| GeneOntologyCellularComponent | catenin complex | 1.76e-03 | 32 | 157 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 1.95e-03 | 9 | 157 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 1.95e-03 | 9 | 157 | 2 | GO:0005943 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | ARHGAP32 ADCY8 ADD2 NLGN3 KCNA4 PTPRD PTPRF RBMX PRICKLE2 PLEKHA5 BSN | 2.04e-03 | 523 | 157 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | basement membrane | 2.30e-03 | 122 | 157 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | calyx of Held | 2.47e-03 | 36 | 157 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | paranodal junction | 2.95e-03 | 11 | 157 | 2 | GO:0033010 | |
| GeneOntologyCellularComponent | proteasome core complex, beta-subunit complex | 2.95e-03 | 11 | 157 | 2 | GO:0019774 | |
| GeneOntologyCellularComponent | asymmetric synapse | ARHGAP32 ADCY8 ADD2 NLGN3 KCNA4 PTPRF RBMX PRICKLE2 PLEKHA5 BSN | 3.31e-03 | 477 | 157 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | juxtaparanode region of axon | 3.52e-03 | 12 | 157 | 2 | GO:0044224 | |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1F FLNA KLHL1 PI4K2A ADCY8 PTPN5 NLGN3 CYFIP1 KCNA1 KCNA2 PTPRF NRSN1 BSN SORL1 | 4.22e-03 | 835 | 157 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | presynaptic active zone | 4.27e-03 | 141 | 157 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | cell body | CACNA1F FLNA KLHL1 PI4K2A ADCY8 PTPN5 NLGN3 PTPN13 CYFIP1 KCNA1 KCNA2 PTPRF NRSN1 BSN SORL1 | 4.37e-03 | 929 | 157 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 5.96e-03 | 96 | 157 | 4 | GO:0010494 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 6.35e-03 | 155 | 157 | 5 | GO:0098685 | |
| GeneOntologyCellularComponent | perikaryon | 6.86e-03 | 223 | 157 | 6 | GO:0043204 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 7.93e-03 | 230 | 157 | 6 | GO:0019898 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.11e-14 | 17 | 133 | 9 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 1.30e-13 | 21 | 133 | 9 | MP:0031415 | |
| MousePheno | decreased carbon dioxide production | 1.62e-13 | 31 | 133 | 10 | MP:0008964 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 4.95e-13 | 47 | 133 | 11 | MP:0031617 | |
| MousePheno | decreased fatty acid oxidation | 5.63e-13 | 24 | 133 | 9 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 1.97e-12 | 27 | 133 | 9 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 2.88e-12 | 28 | 133 | 9 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 8.21e-12 | 31 | 133 | 9 | MP:0031413 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 2.78e-11 | 35 | 133 | 9 | MP:0031618 | |
| MousePheno | abnormal muscle cell glucose uptake | 3.11e-11 | 67 | 133 | 11 | MP:0004130 | |
| MousePheno | abnormal muscle triglyceride level | 3.68e-11 | 36 | 133 | 9 | MP:0031412 | |
| MousePheno | decreased cellular glucose uptake | 5.95e-11 | 53 | 133 | 10 | MP:0003926 | |
| MousePheno | decreased muscle cell glucose uptake | 8.09e-11 | 39 | 133 | 9 | MP:0030022 | |
| MousePheno | abnormal cellular glucose uptake | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 KCNA3 PIK3R1 PSG8 STRA6 | 2.17e-10 | 102 | 133 | 12 | MP:0003925 |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 2.60e-10 | 44 | 133 | 9 | MP:0031023 | |
| MousePheno | abnormal carbon dioxide production | 6.76e-10 | 67 | 133 | 10 | MP:0008962 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 7.24e-10 | 49 | 133 | 9 | MP:0020948 | |
| MousePheno | abnormal vascular wound healing | 1.61e-09 | 73 | 133 | 10 | MP:0004883 | |
| MousePheno | abnormal fatty acid oxidation | 1.80e-09 | 54 | 133 | 9 | MP:0010953 | |
| MousePheno | decreased oxygen consumption | 3.57e-09 | 79 | 133 | 10 | MP:0005290 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 4.77e-09 | 60 | 133 | 9 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 5.55e-09 | 61 | 133 | 9 | MP:0010951 | |
| MousePheno | increased insulin secretion | 8.61e-09 | 64 | 133 | 9 | MP:0003058 | |
| MousePheno | polyphagia | 6.38e-08 | 80 | 133 | 9 | MP:0001433 | |
| MousePheno | decreased susceptibility to Riboviria infection | 7.93e-08 | 82 | 133 | 9 | MP:0020914 | |
| MousePheno | increased incidence of induced tumors | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LYST IL22RA2 PSG8 LTF | 9.23e-08 | 173 | 133 | 12 | MP:0002021 |
| MousePheno | increased incidence of tumors by chemical induction | 9.81e-08 | 141 | 133 | 11 | MP:0004499 | |
| MousePheno | obese | 1.17e-07 | 113 | 133 | 10 | MP:0001261 | |
| MousePheno | decreased energy expenditure | 1.91e-07 | 119 | 133 | 10 | MP:0004890 | |
| MousePheno | abnormal colon morphology | 2.11e-07 | 152 | 133 | 11 | MP:0000495 | |
| MousePheno | increased circulating leptin level | 3.04e-07 | 125 | 133 | 10 | MP:0005669 | |
| MousePheno | abnormal insulin secretion | 6.91e-07 | 171 | 133 | 11 | MP:0003564 | |
| MousePheno | abnormal endocrine pancreas secretion | 9.20e-07 | 176 | 133 | 11 | MP:0014195 | |
| MousePheno | decreased respiratory quotient | 1.00e-06 | 110 | 133 | 9 | MP:0010379 | |
| MousePheno | abnormal blood vessel physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 TRPC6 FREM2 KCNA5 PTPRM PLEKHA5 PSG8 FOXC1 SORL1 | 1.03e-06 | 394 | 133 | 16 | MP:0000249 |
| MousePheno | abnormal glycogen homeostasis | 1.13e-06 | 144 | 133 | 10 | MP:0005438 | |
| MousePheno | abnormal pancreas secretion | 1.35e-06 | 183 | 133 | 11 | MP:0002694 | |
| MousePheno | increased triglyceride level | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK PIEZO2 KCNA6 LPIN2 PSG8 ZC3H12C PAX5 | 1.36e-06 | 354 | 133 | 15 | MP:0005317 |
| MousePheno | abnormal vasculature physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 TRPC6 FREM2 KCNA5 PTPRM PLEKHA5 PSG8 FOXC1 SORL1 | 1.44e-06 | 404 | 133 | 16 | MP:0031170 |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 2.09e-06 | 120 | 133 | 9 | MP:0009786 | |
| MousePheno | abnormal wound healing | 2.28e-06 | 193 | 133 | 11 | MP:0005023 | |
| MousePheno | abnormal pancreatic beta cell physiology | 2.65e-06 | 196 | 133 | 11 | MP:0003562 | |
| MousePheno | insulin resistance | 2.78e-06 | 197 | 133 | 11 | MP:0005331 | |
| MousePheno | decreased susceptibility to viral infection | 2.93e-06 | 125 | 133 | 9 | MP:0002410 | |
| MousePheno | abnormal endocrine pancreas physiology | 3.54e-06 | 202 | 133 | 11 | MP:0010147 | |
| MousePheno | decreased susceptibility to infection | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LYST PTPN13 CIITA PSG8 | 5.70e-06 | 255 | 133 | 12 | MP:0002409 |
| MousePheno | abnormal incidence of induced tumors | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LYST IL22RA2 PSG8 LTF | 9.81e-06 | 269 | 133 | 12 | MP:0013151 |
| MousePheno | abnormal susceptibility to Riboviria infection | 1.12e-05 | 186 | 133 | 10 | MP:0020912 | |
| MousePheno | abnormal large intestine morphology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LOXL1 PSG8 FEM1A LTBP4 | 1.27e-05 | 276 | 133 | 12 | MP:0000489 |
| MousePheno | increased circulating insulin level | CACNA1F PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PIK3R1 RBMX PSG8 | 1.63e-05 | 283 | 133 | 12 | MP:0002079 |
| MousePheno | abnormal iris pigment epithelium | 1.65e-05 | 6 | 133 | 3 | MP:0005199 | |
| MousePheno | increased circulating type I collagen C-terminal telopeptide level | 1.65e-05 | 6 | 133 | 3 | MP:0031074 | |
| MousePheno | abnormal oxygen consumption | 1.69e-05 | 195 | 133 | 10 | MP:0005288 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | CPA6 ARHGAP32 PITRM1 TRPC6 PI4K2A HIPK2 LYST GALR2 ADCY8 FAAH CHRNB3 NLGN3 SLITRK2 KCNA1 SLC8B1 KCNA2 KCNA6 PTPRF AARS2 TENM3 SACS PTPRQ RBM6 PRDM13 NCOA7 PLEKHA5 KRTAP8-1 PAX5 BSN PATJ EPHA10 | 1.88e-05 | 1486 | 133 | 31 | MP:0002067 |
| MousePheno | abnormal pancreas physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK CIITA PIK3R1 PSG8 | 2.22e-05 | 292 | 133 | 12 | MP:0002693 |
| MousePheno | abnormal abdominal fat pad morphology | 4.08e-05 | 262 | 133 | 11 | MP:0000010 | |
| MousePheno | abnormal circulating type I collagen C-terminal telopeptide level | 4.55e-05 | 8 | 133 | 3 | MP:0031072 | |
| MousePheno | abnormal respiratory quotient | 5.05e-05 | 178 | 133 | 9 | MP:0004129 | |
| MousePheno | abnormal food intake | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PEX13 RFX6 CLOCK GSC SCN2A PSG8 DLX5 | 5.27e-05 | 481 | 133 | 15 | MP:0005449 |
| MousePheno | abnormal ciliary body morphology | 7.18e-05 | 24 | 133 | 4 | MP:0005099 | |
| MousePheno | abnormal susceptibility to viral infection | 7.20e-05 | 279 | 133 | 11 | MP:0020185 | |
| MousePheno | increased food intake | 8.04e-05 | 189 | 133 | 9 | MP:0011939 | |
| MousePheno | abnormal circulating leptin level | 8.55e-05 | 236 | 133 | 10 | MP:0005667 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 8.98e-05 | 286 | 133 | 11 | MP:0008873 | |
| MousePheno | abnormal muscle physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 TRPC6 CNTNAP1 HIPK2 PEX13 KCNA1 KCNA3 KCNA5 PTPRM SACS PIK3R1 PSG8 BSN LTBP4 SORL1 | 9.14e-05 | 954 | 133 | 22 | MP:0002106 |
| MousePheno | abnormal iris stroma morphology | 9.62e-05 | 10 | 133 | 3 | MP:0005208 | |
| MousePheno | abnormal skeletal muscle morphology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 FAT3 GSC FREM2 SACS PIK3R1 PSG8 DLX5 | 9.73e-05 | 508 | 133 | 15 | MP:0000759 |
| MousePheno | abnormal consumption behavior | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PEX13 RFX6 CLOCK GSC FAAH SLITRK2 PTPRD SCN2A PSG8 DLX5 | 1.02e-04 | 695 | 133 | 18 | MP:0002069 |
| MousePheno | abnormal circulating triglyceride level | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK PIEZO2 KCNA6 LPIN2 PSG8 ZC3H12C PAX5 | 1.16e-04 | 516 | 133 | 15 | MP:0011969 |
| MousePheno | iris hypoplasia | 1.31e-04 | 11 | 133 | 3 | MP:0006226 | |
| MousePheno | increased tumor incidence | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PSMB9 LYST IL22RA2 PSG8 LTF FEM1A LTBP4 | 1.55e-04 | 530 | 133 | 15 | MP:0002020 |
| MousePheno | abnormal pterygoid bone morphology | 1.74e-04 | 12 | 133 | 3 | MP:0004453 | |
| MousePheno | increased total tissue mass | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK PTPN13 SYNJ2 PSG8 | 1.84e-04 | 364 | 133 | 12 | MP:0012323 |
| MousePheno | increased body weight | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK PTPN13 SYNJ2 PSG8 | 1.84e-04 | 364 | 133 | 12 | MP:0001260 |
| MousePheno | abnormal reflex | CPA6 ARHGAP32 PITRM1 PI4K2A HIPK2 LYST FAAH CHRNB3 NLGN3 SLITRK2 KCNA1 SLC8B1 KCNA2 PTPRF AARS2 SACS PTPRQ RBM6 PRDM13 NCOA7 PLEKHA5 KRTAP8-1 PAX5 BSN PATJ EPHA10 | 1.88e-04 | 1294 | 133 | 26 | MP:0001961 |
| MousePheno | abnormal eating behavior | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PEX13 RFX6 CLOCK GSC PTPRD SCN2A PSG8 DLX5 | 1.98e-04 | 604 | 133 | 16 | MP:0001431 |
| MousePheno | abnormal energy expenditure | 1.98e-04 | 313 | 133 | 11 | MP:0005450 | |
| MousePheno | abnormal fat pad morphology | 2.04e-04 | 314 | 133 | 11 | MP:0005334 | |
| MousePheno | abnormal energy homeostasis | 2.53e-04 | 322 | 133 | 11 | MP:0005448 | |
| MousePheno | abnormal epitympanic recess morphology | 2.68e-04 | 3 | 133 | 2 | MP:0030187 | |
| MousePheno | small malleus processus brevis | 2.68e-04 | 3 | 133 | 2 | MP:0008378 | |
| MousePheno | small Meckel's cartilage | 2.84e-04 | 14 | 133 | 3 | MP:0030026 | |
| MousePheno | decreased circulating triglyceride level | 2.97e-04 | 275 | 133 | 10 | MP:0002644 | |
| MousePheno | decreased tympanic ring size | 3.52e-04 | 15 | 133 | 3 | MP:0006020 | |
| MousePheno | abnormal somatic sensory system morphology | CACNA1F FAT3 HIPK2 LAMC3 MSI1 GALR2 PTPN13 PTPRF TENM3 SYNJ2 PTPRQ PRDM13 DLX5 STRA6 PPIP5K2 BSN FOXC1 | 3.56e-04 | 702 | 133 | 17 | MP:0000959 |
| MousePheno | abnormal triglyceride level | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK PIEZO2 KCNA6 PIK3R1 LPIN2 PSG8 ZC3H12C PAX5 | 3.72e-04 | 639 | 133 | 16 | MP:0000187 |
| MousePheno | increased lipid level | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 USP11 PSG9 PSG11 SERF1A CLOCK FAAH PIEZO2 KCNA6 LPIN2 SMPD1 PSG8 ZC3H12C PAX5 | 4.10e-04 | 847 | 133 | 19 | MP:0014460 |
| MousePheno | abnormal tumor susceptibility | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PSMB8 PSMB9 LYST IL22RA2 PSG8 LTF FEM1A LTBP4 | 4.48e-04 | 650 | 133 | 16 | MP:0002166 |
| MousePheno | decreased triglyceride level | 4.89e-04 | 348 | 133 | 11 | MP:0005318 | |
| MousePheno | increased body size | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK PTPN13 SYNJ2 PSG8 | 5.29e-04 | 409 | 133 | 12 | MP:0001264 |
| MousePheno | abnormal intrinsic tongue muscle morphology | 5.32e-04 | 4 | 133 | 2 | MP:0030208 | |
| MousePheno | iris stroma hypoplasia | 5.32e-04 | 4 | 133 | 2 | MP:0006230 | |
| MousePheno | increased exploration in new environment | 5.74e-04 | 150 | 133 | 7 | MP:0001415 | |
| MousePheno | abnormal motor coordination/balance | ARHGAP32 KLHL1 PITRM1 CNTNAP1 HIPK2 MSI1 LYST FAAH NLGN3 SLITRK2 KCNA1 SLC8B1 KCNA2 PTPRD SACS LPIN2 SMPD1 BSN EPHA10 | 5.95e-04 | 873 | 133 | 19 | MP:0001516 |
| MousePheno | abnormal Meckel's cartilage morphology | 6.04e-04 | 41 | 133 | 4 | MP:0005587 | |
| MousePheno | abnormal nasal capsule morphology | 6.19e-04 | 18 | 133 | 3 | MP:0004726 | |
| MousePheno | abnormal susceptibility to infection | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PSMB9 LYST PTPN13 CIITA PIK3R1 SMPD1 PSG8 MUC5AC | 6.43e-04 | 672 | 133 | 16 | MP:0001793 |
| MousePheno | impaired glucose tolerance | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 RFX6 CLOCK PIK3R1 PSG8 PAX5 | 6.57e-04 | 480 | 133 | 13 | MP:0005293 |
| MousePheno | abnormal endocrine gland physiology | 6.95e-04 | 363 | 133 | 11 | MP:0013561 | |
| MousePheno | aortic arch coarctation | 8.82e-04 | 5 | 133 | 2 | MP:0010526 | |
| Domain | K_chnl_volt-dep_Kv1 | 1.97e-14 | 8 | 156 | 7 | IPR003972 | |
| Domain | Ig_2 | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PSG8 LILRB5 LILRA4 | 8.91e-13 | 73 | 156 | 12 | PF13895 |
| Domain | ig | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PTPRD HMCN1 PTPRM PSG8 LILRB5 LILRA4 | 6.38e-11 | 190 | 156 | 15 | PF00047 |
| Domain | Immunoglobulin | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PTPRD HMCN1 PTPRM PSG8 LILRB5 LILRA4 | 6.38e-11 | 190 | 156 | 15 | IPR013151 |
| Domain | Ig-like_fold | FLNA FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 HLA-DQA1 PSG9 PSG11 LILRB2 PKHD1L1 IL22RA2 PTPRD PTPRF HMCN1 PTPRM PKHD1 PSG8 LILRB5 EPHA10 LILRA4 SORL1 | 9.56e-10 | 706 | 156 | 25 | IPR013783 |
| Domain | Channel_four-helix_dom | 1.00e-09 | 57 | 156 | 9 | IPR027359 | |
| Domain | - | 1.00e-09 | 57 | 156 | 9 | 1.20.120.350 | |
| Domain | IGc2 | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PTPRD PTPRF HMCN1 PSG8 LILRB5 LILRA4 | 1.25e-09 | 235 | 156 | 15 | SM00408 |
| Domain | Ig_sub2 | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PTPRD PTPRF HMCN1 PSG8 LILRB5 LILRA4 | 1.25e-09 | 235 | 156 | 15 | IPR003598 |
| Domain | - | FLNA FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 HLA-DQA1 PSG9 PSG11 PKHD1L1 IL22RA2 PTPRD PTPRF HMCN1 PTPRM PKHD1 PSG8 LILRB5 EPHA10 LILRA4 SORL1 | 1.40e-09 | 663 | 156 | 24 | 2.60.40.10 |
| Domain | K_chnl_volt-dep_Kv | 1.91e-09 | 27 | 156 | 7 | IPR003968 | |
| Domain | VG_K_chnl | 8.82e-09 | 33 | 156 | 7 | IPR028325 | |
| Domain | Ion_trans_dom | CACNA1F TRPC6 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A | 4.00e-08 | 114 | 156 | 10 | IPR005821 |
| Domain | Ion_trans | CACNA1F TRPC6 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A | 4.00e-08 | 114 | 156 | 10 | PF00520 |
| Domain | IG | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 LILRB2 PTPRD PTPRF HMCN1 PTPRM PSG8 LILRB5 LILRA4 | 9.03e-08 | 421 | 156 | 17 | SM00409 |
| Domain | Ig_sub | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 LILRB2 PTPRD PTPRF HMCN1 PTPRM PSG8 LILRB5 LILRA4 | 9.03e-08 | 421 | 156 | 17 | IPR003599 |
| Domain | IG_LIKE | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 HLA-DQA1 PSG9 PSG11 LILRB2 PTPRD PTPRF HMCN1 PTPRM PSG8 LILRB5 LILRA4 | 1.57e-07 | 491 | 156 | 18 | PS50835 |
| Domain | Ig-like_dom | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 HLA-DQA1 PSG9 PSG11 LILRB2 PTPRD PTPRF HMCN1 PTPRM PSG8 LILRB5 LILRA4 | 2.24e-07 | 503 | 156 | 18 | IPR007110 |
| Domain | BTB_2 | 2.77e-07 | 53 | 156 | 7 | PF02214 | |
| Domain | T1-type_BTB | 2.77e-07 | 53 | 156 | 7 | IPR003131 | |
| Domain | Ig_V-set | 9.23e-07 | 199 | 156 | 11 | IPR013106 | |
| Domain | V-set | 3.41e-06 | 184 | 156 | 10 | PF07686 | |
| Domain | PTPc | 1.17e-05 | 36 | 156 | 5 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.75e-05 | 39 | 156 | 5 | PS50055 | |
| Domain | PTPase_domain | 2.24e-05 | 41 | 156 | 5 | IPR000242 | |
| Domain | Y_phosphatase | 2.24e-05 | 41 | 156 | 5 | PF00102 | |
| Domain | Cadherin_C | 5.17e-05 | 25 | 156 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 5.17e-05 | 25 | 156 | 4 | IPR000233 | |
| Domain | EGF-like_CS | 7.01e-05 | 261 | 156 | 10 | IPR013032 | |
| Domain | Catenin_binding_dom | 9.45e-05 | 29 | 156 | 4 | IPR027397 | |
| Domain | - | 9.45e-05 | 29 | 156 | 4 | 4.10.900.10 | |
| Domain | PTPc_motif | 1.33e-04 | 59 | 156 | 5 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.33e-04 | 59 | 156 | 5 | IPR003595 | |
| Domain | BTB | 1.37e-04 | 180 | 156 | 8 | SM00225 | |
| Domain | BTB/POZ_dom | 1.66e-04 | 185 | 156 | 8 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 1.92e-04 | 189 | 156 | 8 | IPR011333 | |
| Domain | Rhs_assc_core | 2.07e-04 | 3 | 156 | 2 | IPR022385 | |
| Domain | Transferrin | 2.07e-04 | 3 | 156 | 2 | PF00405 | |
| Domain | Transferrin | 2.07e-04 | 3 | 156 | 2 | IPR016357 | |
| Domain | TRANSFERRIN_LIKE_4 | 2.07e-04 | 3 | 156 | 2 | PS51408 | |
| Domain | PI3K_P85_iSH2 | 2.07e-04 | 3 | 156 | 2 | IPR032498 | |
| Domain | TRANSFERRIN_LIKE_1 | 2.07e-04 | 3 | 156 | 2 | PS00205 | |
| Domain | TRANSFERRIN_LIKE_2 | 2.07e-04 | 3 | 156 | 2 | PS00206 | |
| Domain | TRANSFERRIN_LIKE_3 | 2.07e-04 | 3 | 156 | 2 | PS00207 | |
| Domain | Transferrin_Fe_BS | 2.07e-04 | 3 | 156 | 2 | IPR018195 | |
| Domain | TR_FER | 2.07e-04 | 3 | 156 | 2 | SM00094 | |
| Domain | Transferrin-like_dom | 2.07e-04 | 3 | 156 | 2 | IPR001156 | |
| Domain | PI3K_P85_iSH2 | 2.07e-04 | 3 | 156 | 2 | PF16454 | |
| Domain | EGF_2 | 3.96e-04 | 265 | 156 | 9 | PS01186 | |
| Domain | CA | 4.10e-04 | 115 | 156 | 6 | SM00112 | |
| Domain | Tox-GHH_dom | 4.11e-04 | 4 | 156 | 2 | IPR028916 | |
| Domain | G8_domain | 4.11e-04 | 4 | 156 | 2 | IPR019316 | |
| Domain | G8 | 4.11e-04 | 4 | 156 | 2 | PS51484 | |
| Domain | Tox-GHH | 4.11e-04 | 4 | 156 | 2 | PF15636 | |
| Domain | G8 | 4.11e-04 | 4 | 156 | 2 | SM01225 | |
| Domain | Ten_N | 4.11e-04 | 4 | 156 | 2 | IPR009471 | |
| Domain | Ten_N | 4.11e-04 | 4 | 156 | 2 | PF06484 | |
| Domain | G8 | 4.11e-04 | 4 | 156 | 2 | PF10162 | |
| Domain | TENEURIN_N | 4.11e-04 | 4 | 156 | 2 | PS51361 | |
| Domain | Cadherin | 4.71e-04 | 118 | 156 | 6 | IPR002126 | |
| Domain | RRM_dom | 6.54e-04 | 227 | 156 | 8 | IPR000504 | |
| Domain | YD | 6.82e-04 | 5 | 156 | 2 | IPR006530 | |
| Domain | PI3kinase_P85 | 6.82e-04 | 5 | 156 | 2 | IPR001720 | |
| Domain | RRM | 7.12e-04 | 230 | 156 | 8 | PS50102 | |
| Domain | TYR_PHOSPHATASE_1 | 7.70e-04 | 86 | 156 | 5 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 8.12e-04 | 87 | 156 | 5 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 8.12e-04 | 87 | 156 | 5 | PS50056 | |
| Domain | EGF | 8.19e-04 | 235 | 156 | 8 | SM00181 | |
| Domain | PbH1 | 1.02e-03 | 6 | 156 | 2 | SM00710 | |
| Domain | PbH1 | 1.02e-03 | 6 | 156 | 2 | IPR006626 | |
| Domain | - | 1.04e-03 | 244 | 156 | 8 | 3.30.70.330 | |
| Domain | - | 1.05e-03 | 92 | 156 | 5 | 3.90.190.10 | |
| Domain | EGF-like_dom | 1.19e-03 | 249 | 156 | 8 | IPR000742 | |
| Domain | EGF_1 | 1.38e-03 | 255 | 156 | 8 | PS00022 | |
| Domain | FN3 | 1.44e-03 | 199 | 156 | 7 | PS50853 | |
| Domain | Fibrinogen_C | 1.44e-03 | 27 | 156 | 3 | PF00147 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.45e-03 | 99 | 156 | 5 | IPR029021 | |
| Domain | Nucleotide-bd_a/b_plait | 1.49e-03 | 258 | 156 | 8 | IPR012677 | |
| Domain | FBG | 1.78e-03 | 29 | 156 | 3 | SM00186 | |
| Domain | Pectin_lyase_fold/virulence | 1.88e-03 | 8 | 156 | 2 | IPR011050 | |
| Domain | RBM1CTR | 1.88e-03 | 8 | 156 | 2 | PF08081 | |
| Domain | RBM1CTR | 1.88e-03 | 8 | 156 | 2 | IPR012604 | |
| Domain | FN3_dom | 1.90e-03 | 209 | 156 | 7 | IPR003961 | |
| Domain | - | 1.97e-03 | 30 | 156 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.97e-03 | 30 | 156 | 3 | IPR014716 | |
| Domain | Cadherin_CS | 2.22e-03 | 109 | 156 | 5 | IPR020894 | |
| Domain | RRM | 2.35e-03 | 217 | 156 | 7 | SM00360 | |
| Domain | FIBRINOGEN_C_1 | 2.37e-03 | 32 | 156 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.37e-03 | 32 | 156 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 2.37e-03 | 32 | 156 | 3 | PS51406 | |
| Domain | RFX_DNA_binding | 2.40e-03 | 9 | 156 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 2.40e-03 | 9 | 156 | 2 | IPR003150 | |
| Domain | RFX_DBD | 2.40e-03 | 9 | 156 | 2 | PS51526 | |
| Domain | - | 2.41e-03 | 218 | 156 | 7 | 1.10.10.10 | |
| Domain | fn3 | 2.42e-03 | 162 | 156 | 6 | PF00041 | |
| Domain | CADHERIN_1 | 2.59e-03 | 113 | 156 | 5 | PS00232 | |
| Domain | Cadherin | 2.59e-03 | 113 | 156 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 2.70e-03 | 114 | 156 | 5 | PS50268 | |
| Domain | - | 2.70e-03 | 114 | 156 | 5 | 2.60.40.60 | |
| Domain | Cadherin-like | 2.91e-03 | 116 | 156 | 5 | IPR015919 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PIK3R3 PTPN5 PIK3R1 PSG8 MAP2K2 | 1.70e-08 | 188 | 129 | 13 | MM15828 |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 2.27e-08 | 99 | 129 | 10 | MM14624 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 7.92e-08 | 41 | 129 | 7 | MM14546 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.12e-07 | 43 | 129 | 7 | M1056 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PIK3R1 PSG8 | 2.11e-07 | 194 | 129 | 12 | M16312 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.11e-07 | 158 | 129 | 11 | MM14812 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LOXL1 PSG8 LTBP4 | 4.29e-06 | 258 | 129 | 12 | MM14572 |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 5.97e-06 | 50 | 129 | 6 | MM14641 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 6.24e-06 | 14 | 129 | 4 | M668 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 6.24e-06 | 14 | 129 | 4 | MM1489 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 8.43e-06 | 53 | 129 | 6 | M662 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | ADCY8 CHRNB3 NLGN3 SLITRK2 KCNA1 KCNA2 KCNA3 KCNA4 PTPRD KCNA5 KCNA6 KCNA7 PTPRF | 1.21e-05 | 335 | 129 | 13 | MM14503 |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 1.45e-05 | 17 | 129 | 4 | M111 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 1.45e-05 | 17 | 129 | 4 | MM1491 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | PIK3R3 CNTNAP1 FAAH NLGN3 KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 PIK3R1 SCN2A | 3.15e-05 | 367 | 129 | 13 | M48346 |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 3.16e-05 | 98 | 129 | 7 | MM14545 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 4.36e-05 | 103 | 129 | 7 | M1073 | |
| Pathway | REACTOME_PI_METABOLISM | 7.28e-05 | 77 | 129 | 6 | MM14590 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | ADCY8 CHRNB3 NLGN3 SLITRK2 KCNA1 KCNA2 KCNA3 KCNA4 PTPRD KCNA5 KCNA6 KCNA7 PTPRF | 1.00e-04 | 411 | 129 | 13 | M735 |
| Pathway | BIOCARTA_BARRESTIN_PATHWAY | 1.17e-04 | 11 | 129 | 3 | MM1501 | |
| Pathway | REACTOME_PI_METABOLISM | 1.18e-04 | 84 | 129 | 6 | M676 | |
| Pathway | BIOCARTA_BARRESTIN_PATHWAY | 1.55e-04 | 12 | 129 | 3 | M7772 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LILRB2 CYFIP1 PSG8 LTF LILRB5 LILRA4 | 2.42e-04 | 511 | 129 | 14 | MM15330 |
| Pathway | REACTOME_HEMOSTASIS | FLNA FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PIK3R3 TRPC6 PIK3R1 PSG8 | 7.33e-04 | 571 | 129 | 14 | MM14472 |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 7.62e-04 | 20 | 129 | 3 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 7.62e-04 | 20 | 129 | 3 | MM14991 | |
| Pubmed | Insulin acutely decreases hepatic fatty acid synthase activity. | 8.81e-21 | 15 | 159 | 10 | 16054098 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 4.88e-19 | 13 | 159 | 9 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 4.88e-19 | 13 | 159 | 9 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 4.88e-19 | 13 | 159 | 9 | 16638824 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 20044046 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 32150576 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 6265583 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 4.88e-19 | 13 | 159 | 9 | 12832451 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 4.88e-19 | 13 | 159 | 9 | 21670291 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 22162753 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 2702644 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 8380065 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 1279194 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 25724769 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 4.88e-19 | 13 | 159 | 9 | 22092845 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 11801635 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 4.88e-19 | 13 | 159 | 9 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 4.88e-19 | 13 | 159 | 9 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 4.88e-19 | 13 | 159 | 9 | 23800882 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 19285068 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 21760897 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 4.88e-19 | 13 | 159 | 9 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 4.88e-19 | 13 | 159 | 9 | 39168268 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 8402684 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 16619040 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 4.88e-19 | 13 | 159 | 9 | 8209741 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 4.88e-19 | 13 | 159 | 9 | 21949477 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 26219866 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 2133556 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 32521208 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 19406938 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 4.88e-19 | 13 | 159 | 9 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 4.88e-19 | 13 | 159 | 9 | 19358828 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 16680193 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 4.88e-19 | 13 | 159 | 9 | 34058224 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 10964771 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 32169849 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 4.88e-19 | 13 | 159 | 9 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 4.88e-19 | 13 | 159 | 9 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 4.88e-19 | 13 | 159 | 9 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 4.88e-19 | 13 | 159 | 9 | 23935487 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 15331748 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 4.88e-19 | 13 | 159 | 9 | 22406619 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 4.88e-19 | 13 | 159 | 9 | 25972571 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 19008452 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 4.88e-19 | 13 | 159 | 9 | 15220458 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 18843289 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 15207636 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 21081647 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 11133662 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 11483763 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 2164599 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 29396368 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 18003729 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 4.88e-19 | 13 | 159 | 9 | 33352461 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 38381498 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 20739537 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 4.88e-19 | 13 | 159 | 9 | 27695943 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 20404914 | ||
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 4.88e-19 | 13 | 159 | 9 | 32027621 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 4.88e-19 | 13 | 159 | 9 | 27777319 | |
| Pubmed | 4.88e-19 | 13 | 159 | 9 | 18848945 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.36e-18 | 14 | 159 | 9 | 34666041 | |
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 1.36e-18 | 14 | 159 | 9 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 1.36e-18 | 14 | 159 | 9 | 32209360 | |
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 11994468 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 11850617 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 1.36e-18 | 14 | 159 | 9 | 26196244 | |
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 8896983 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 22962327 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 17623671 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.36e-18 | 14 | 159 | 9 | 18794798 | |
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 23469261 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 18454175 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 22159884 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 29907459 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 36719377 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 23780386 | ||
| Pubmed | 1.36e-18 | 14 | 159 | 9 | 28567513 | ||
| Interaction | PSG4 interactions | 5.40e-12 | 8 | 156 | 6 | int:PSG4 | |
| Interaction | PSG1 interactions | 5.62e-12 | 51 | 156 | 10 | int:PSG1 | |
| Interaction | NLGN3 interactions | FLNA PSG1 PSG3 PSG4 PSG5 PSG11 PIK3R3 NLGN3 PTPRD PIK3R1 RBFOX2 | 2.94e-10 | 99 | 156 | 11 | int:NLGN3 |
| Interaction | PTPRA interactions | PTPN5 NHSL1 PTPN13 CYFIP1 KCNA2 PTPRD PTPRF PTPRM PIK3R1 PTPRQ | 6.11e-07 | 164 | 156 | 10 | int:PTPRA |
| Interaction | PSG3 interactions | 6.17e-07 | 22 | 156 | 5 | int:PSG3 | |
| Interaction | FYN interactions | ARHGAP32 PIK3R3 TRPC6 CNTNAP1 ADD2 PTPN5 KCNA2 KCNA3 KCNA4 PTPRD KCNA5 PTPRF PIK3R1 SKAP1 RBFOX2 | 1.35e-06 | 431 | 156 | 15 | int:FYN |
| Interaction | PSG5 interactions | 4.50e-06 | 5 | 156 | 3 | int:PSG5 | |
| Interaction | KCNA1 interactions | 7.01e-06 | 35 | 156 | 5 | int:KCNA1 | |
| Interaction | KCNA4 interactions | 1.44e-05 | 68 | 156 | 6 | int:KCNA4 | |
| Interaction | PSG8 interactions | 1.56e-05 | 41 | 156 | 5 | int:PSG8 | |
| Interaction | KCNAB1 interactions | 3.85e-05 | 25 | 156 | 4 | int:KCNAB1 | |
| Interaction | PTPRQ interactions | 3.85e-05 | 25 | 156 | 4 | int:PTPRQ | |
| Interaction | DOLK interactions | 6.64e-05 | 55 | 156 | 5 | int:DOLK | |
| Interaction | KCTD13 interactions | FLNA ARHGAP32 FN1 ARHGAP23 PPP1R12A CNTNAP1 USP25 KANK2 ADD2 NHSL1 NLGN3 FASN CYFIP1 KCNA1 TENM4 SACS G3BP2 RBMX SCN2A EIF3L OSBPL6 PRICKLE2 PLEKHA5 BSN CAPRIN1 | 6.91e-05 | 1394 | 156 | 25 | int:KCTD13 |
| Interaction | PIK3CB interactions | 8.55e-05 | 93 | 156 | 6 | int:PIK3CB | |
| Interaction | CDH1 interactions | FLNA ARHGAP32 DSC3 ARHGAP23 KANK2 NHSL1 FASN PTPRD PTPRF TENM3 PTPRM SYNJ2 PIK3R1 PTPRQ PLEKHA5 PATJ CAPRIN1 | 9.79e-05 | 768 | 156 | 17 | int:CDH1 |
| Cytoband | 19q13.2 | 3.46e-10 | 164 | 159 | 10 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 LILRB2 LENG8 KCNA7 ZNF544 PSG8 IL4I1 LTBP4 LILRB5 LILRA4 MIA | 3.78e-08 | 1192 | 159 | 19 | chr19q13 |
| Cytoband | 21q22.1 | 3.40e-04 | 39 | 159 | 3 | 21q22.1 | |
| Cytoband | 19q13.1-q13.2 | 4.22e-04 | 9 | 159 | 2 | 19q13.1-q13.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.04e-21 | 11 | 118 | 10 | 1315 | |
| GeneFamily | Potassium voltage-gated channels | 6.57e-09 | 40 | 118 | 7 | 274 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.22e-06 | 163 | 118 | 9 | 590 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 9.47e-06 | 21 | 118 | 4 | 813 | |
| GeneFamily | CD molecules|Type II classical cadherins | 7.39e-05 | 13 | 118 | 3 | 1186 | |
| GeneFamily | Fibronectin type III domain containing | 8.63e-05 | 160 | 118 | 7 | 555 | |
| GeneFamily | Transferrins | 1.26e-04 | 3 | 118 | 2 | 908 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 4.17e-04 | 5 | 118 | 2 | 1182 | |
| GeneFamily | RNA binding motif containing | 4.98e-04 | 213 | 118 | 7 | 725 | |
| GeneFamily | Regulatory factor X family | 1.15e-03 | 8 | 118 | 2 | 1153 | |
| GeneFamily | Dyneins, axonemal | 5.39e-03 | 17 | 118 | 2 | 536 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 6.04e-03 | 18 | 118 | 2 | 812 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 7.66e-15 | 35 | 158 | 10 | MM757 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LYST PIK3R1 PSG8 SORL1 | 2.84e-14 | 75 | 158 | 12 | MM605 |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 2.08e-13 | 32 | 158 | 9 | MM2 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.07e-11 | 93 | 158 | 11 | M40279 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.15e-11 | 48 | 158 | 9 | MM531 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PTPRF PSG8 LTF PATJ | 3.69e-11 | 135 | 158 | 12 | MM965 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 NHSL1 PSG8 LTF PATJ FXYD2 CDH11 | 2.12e-10 | 284 | 158 | 15 | MM987 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 HIPK2 PEX13 NHSL1 PTPN13 TENM4 PTPRF RBM6 PSG8 EMP2 RIOK2 CAPRIN1 RBFOX2 FOXC1 | 7.60e-10 | 741 | 158 | 22 | MM1037 |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.19e-09 | 182 | 158 | 12 | MM993 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 2.87e-09 | 87 | 158 | 9 | MM851 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | FLNA B4GALNT1 FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PSG8 | 9.66e-09 | 219 | 158 | 12 | MM3826 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 1.67e-08 | 230 | 158 | 12 | MM986 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 1.71e-08 | 143 | 158 | 10 | MM989 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CR1L CYFIP1 NCOA7 PSG8 SMOX | 4.05e-08 | 302 | 158 | 13 | MM16604 |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 4.13e-08 | 201 | 158 | 11 | MM1006 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PSMB8 PEX13 FAAH PTPRF PSG8 LTF SORL1 | 6.85e-08 | 436 | 158 | 15 | MM1326 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 8.64e-08 | 128 | 158 | 9 | MM1000 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | ZNF703 FLNA FN1 PSG1 PSG4 PSG5 PRSS12 PIK3R3 CNTNAP1 PSMB9 TENM4 LOXL1 RBMX SMPD1 CDH6 FOXC2 | 3.61e-07 | 567 | 158 | 16 | M2129 |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 4.20e-07 | 201 | 158 | 10 | MM1294 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 5.50e-07 | 159 | 158 | 9 | MM760 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | FLNA FN1 LAMC3 KANK2 PIEZO2 CYFIP1 HMCN1 NCOA7 EMP2 LTBP4 CDH11 FOXC1 FOXC2 | 6.57e-07 | 385 | 158 | 13 | M39264 |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | B4GALNT1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 FASN POLR1B PSG8 PAX5 LTF | 8.97e-07 | 463 | 158 | 14 | MM1011 |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 1.01e-06 | 171 | 158 | 9 | M40134 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 1.13e-06 | 224 | 158 | 10 | M40145 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | ZNF703 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CNTNAP1 HIPK2 KCNA4 PIK3R1 SMPD1 PSG8 FEM1A MUC5AC CDH6 MIA | 1.38e-06 | 871 | 158 | 19 | MM1005 |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 2.89e-06 | 102 | 158 | 7 | M10290 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | FN1 FAT3 MSI1 PTPN13 HOXC6 TENM4 KRTAP13-4 PTPRM LOXL1 PRICKLE2 PLEKHA5 DLX5 EMP2 CDH11 RBFOX2 FOXC1 FOXC2 | 4.16e-06 | 767 | 158 | 17 | M39209 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | B4GALNT1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 FASN PTPRF PKHD1 PSG8 | 4.70e-06 | 534 | 158 | 14 | MM1050 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | B4GALNT1 KLHL1 DSC3 PRSS12 RFX6 TMEM255B GSC GALR2 ADCY8 HOXC6 KCNA1 KCNA3 KCNA5 SKAP1 PRDM13 DLX5 PAX5 CDH6 EPHA10 FOXC1 | 1.33e-05 | 1115 | 158 | 20 | M10371 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 1.63e-05 | 303 | 158 | 10 | M39040 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 PEX13 PTPRF RBM6 PSG8 EMP2 CAPRIN1 | 2.11e-05 | 694 | 158 | 15 | MM1039 |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | PSG3 PSG4 PSG6 PSG9 PIK3R3 PSMB8 HIPK2 PTPN13 HOXC6 HMCN1 LOXL1 LPIN2 PRICKLE2 PLEKHA5 PATJ RBFOX2 | 2.30e-05 | 786 | 158 | 16 | M10961 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | FLNA KRTAP13-2 PRSS12 HIPK2 NHSL1 PTPN13 TENM4 KRTAP13-4 PTPRF RBM6 KRTAP8-1 RIOK2 RBFOX2 FOXC1 | 4.18e-05 | 650 | 158 | 14 | MM1042 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PTPN13 PSG8 EMP2 SMOX | 4.46e-05 | 490 | 158 | 12 | MM1001 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 PEX13 PTPRF PSG8 EMP2 CAPRIN1 | 7.78e-05 | 689 | 158 | 14 | MM1041 |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 7.82e-05 | 365 | 158 | 10 | M39018 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 8.00e-05 | 38 | 158 | 4 | M1962 | |
| Coexpression | FURUKAWA_DUSP6_TARGETS_PCI35_UP | 8.06e-05 | 73 | 158 | 5 | M6998 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | FLNA PRSS12 HIPK2 NHSL1 PTPN13 TENM4 KRTAP13-4 PTPRF RBM6 KRTAP8-1 RIOK2 RBFOX2 FOXC1 | 8.80e-05 | 610 | 158 | 13 | M3854 |
| Coexpression | ODONNELL_METASTASIS_UP | 9.77e-05 | 76 | 158 | 5 | M265 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | FLNA FN1 PPP1R12A TRPC6 LAMC3 SERF1A KANK2 MELTF PIEZO2 PTPRM NCOA7 EMP2 CDH6 CDH11 FOXC1 | 9.81e-05 | 795 | 158 | 15 | M39050 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 9.94e-05 | 176 | 158 | 7 | M39223 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 1.31e-04 | 43 | 158 | 4 | MM837 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | ZNF703 B4GALNT1 DSC3 TRPC6 GSC GALR2 ADCY8 SLITRK2 CYFIP1 HOXC6 KCNA1 KCNA3 KCNA5 PAX5 CDH6 CDH11 EPHA10 | 1.78e-04 | 1035 | 158 | 17 | M9898 |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 1.80e-04 | 136 | 158 | 6 | M2005 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | FLNA KRTAP13-2 PRSS12 HIPK2 NHSL1 PTPN13 TENM4 KRTAP13-4 PTPRF KRTAP8-1 RIOK2 RBFOX2 FOXC1 | 1.88e-04 | 659 | 158 | 13 | MM1040 |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN | 2.12e-04 | 199 | 158 | 7 | M9434 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP | 2.12e-04 | 199 | 158 | 7 | M6895 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 2.18e-04 | 49 | 158 | 4 | MM1287 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 2.19e-04 | 200 | 158 | 7 | M9186 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 2.64e-04 | 146 | 158 | 6 | MM856 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | HLA-DQA1 HIPK2 PEX13 NHSL1 PTPN13 TENM4 PTPRF RBM6 EMP2 RIOK2 CAPRIN1 RBFOX2 FOXC1 | 2.93e-04 | 690 | 158 | 13 | M12224 |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 2.94e-04 | 210 | 158 | 7 | M2010 | |
| Coexpression | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP | 2.96e-04 | 53 | 158 | 4 | M14365 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 3.08e-04 | 97 | 158 | 5 | MM3789 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 3.59e-04 | 217 | 158 | 7 | MM861 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | FLNA PRSS12 HIPK2 NHSL1 PTPN13 TENM4 KRTAP13-4 PTPRF KRTAP8-1 RIOK2 RBFOX2 FOXC1 | 3.68e-04 | 615 | 158 | 12 | M8673 |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP | 3.77e-04 | 156 | 158 | 6 | M360 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 3.89e-04 | 102 | 158 | 5 | MM1064 | |
| Coexpression | HUPER_BREAST_BASAL_VS_LUMINAL_DN | 4.19e-04 | 58 | 158 | 4 | M5505 | |
| Coexpression | DAWSON_METHYLATED_IN_LYMPHOMA_TCL1 | 4.47e-04 | 59 | 158 | 4 | MM528 | |
| Coexpression | DAWSON_METHYLATED_IN_LYMPHOMA_TCL1 | 4.47e-04 | 59 | 158 | 4 | M1238 | |
| CoexpressionAtlas | placenta | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 TRPC6 LAMC3 TENM3 PSG8 DLX5 STRA6 | 6.66e-09 | 349 | 156 | 16 | placenta |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | FLNA USP11 FAT3 TRPC6 SLITRK2 HOXC6 TENM4 PTPRD HMCN1 TENM3 PIK3R1 LOXL1 SCN2A CDH6 CDH11 | 2.99e-08 | 337 | 156 | 15 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | FLNA FAT3 TRPC6 HOXC6 TENM4 HMCN1 TENM3 PIK3R1 LOXL1 SCN2A LTBP4 CDH6 CDH11 | 8.47e-08 | 265 | 156 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | FAT3 HIPK2 MSI1 FREM2 PTPN13 HOXC6 TENM4 HMCN1 TENM3 PTPRM SCN2A LPIN2 CDH6 CDH11 FOXC2 | 1.02e-07 | 370 | 156 | 15 | gudmap_kidney_P3_CapMes_Crym_500 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | PITRM1 HLA-DQA1 FAT3 MSI1 LYST HOXC6 HMCN1 TENM3 PTPRM LPIN2 POLR1B EMP2 SMOX RIOK2 CDH6 CDH11 FOXC1 FOXC2 | 1.14e-06 | 639 | 156 | 18 | gudmap_kidney_P0_CapMes_Crym_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | FLNA USP11 FAT3 TRPC6 SLITRK2 HOXC6 TENM4 HMCN1 TENM3 PIK3R1 SCN2A CDH6 CDH11 | 2.25e-06 | 354 | 156 | 13 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.18e-06 | 207 | 156 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | FLNA USP11 FAT3 TRPC6 SLITRK2 HOXC6 TENM4 PTPRD HMCN1 TENM3 LTBP4 CDH11 | 3.27e-06 | 310 | 156 | 12 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 3.92e-06 | 166 | 156 | 9 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | FLNA USP11 FAT3 TRPC6 SLITRK2 HOXC6 TENM4 HMCN1 TENM3 LOXL1 LTBP4 CDH11 | 7.43e-06 | 336 | 156 | 12 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | FLNA FAT3 PIK3R3 TRPC6 PTPN13 HOXC6 TENM4 PTPRD PTPRF HMCN1 TENM3 PIK3R1 LOXL1 SCN2A KRT20 LTBP4 CDH6 CDH11 | 8.79e-06 | 740 | 156 | 18 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | FAT3 HIPK2 MSI1 LYST FREM2 PTPN13 HOXC6 TENM4 HMCN1 TENM3 PTPRM SCN2A LPIN2 POLR1B SMOX CDH6 CDH11 FOXC2 | 1.04e-05 | 749 | 156 | 18 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.27e-05 | 146 | 156 | 8 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | FN1 FAT3 TRPC6 SLITRK2 HOXC6 TENM4 HMCN1 TENM3 LOXL1 LTBP4 CDH6 CDH11 | 1.52e-05 | 361 | 156 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | PRSS12 HLA-DQA1 FAT3 PSMB8 PSMB9 CLOCK PTPN13 PIEZO2 HOXC6 HMCN1 PIK3R1 LOXL1 SCN2A PTPRQ SMPD1 EMP2 LTBP4 CDH11 | 1.72e-05 | 778 | 156 | 18 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.15e-05 | 114 | 156 | 7 | gudmap_kidney_P3_CapMes_Crym_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | FLNA FN1 FAT3 TRPC6 FREM2 PTPN13 HOXC6 TENM4 HMCN1 TENM3 PIK3R1 LOXL1 SCN2A KRT20 PPIP5K2 LTBP4 CDH6 CDH11 | 2.37e-05 | 797 | 156 | 18 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.49e-05 | 168 | 156 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | PPP1R12A HIPK2 PKHD1 NCOA7 PLEKHA5 PATJ FXYD2 CAPRIN1 CDH6 RBFOX2 FOXC1 SORL1 | 4.36e-05 | 402 | 156 | 12 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_100 | 4.49e-05 | 10 | 156 | 3 | gudmap_kidney_P1_CapMes_Crym_k2_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | HLA-DQA1 PSMB8 PSMB9 PIEZO2 HMCN1 PIK3R1 LOXL1 SCN2A PTPRQ EMP2 LTBP4 CDH11 | 5.03e-05 | 408 | 156 | 12 | gudmap_kidney_adult_RenalCapsule_500 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 6.04e-05 | 291 | 156 | 10 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 6.43e-05 | 93 | 156 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 6.58e-05 | 294 | 156 | 10 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.72e-05 | 58 | 156 | 5 | gudmap_kidney_P0_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 7.56e-05 | 31 | 156 | 4 | gudmap_kidney_P1_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 7.56e-05 | 31 | 156 | 4 | gudmap_kidney_P0_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | FLNA FN1 FAT3 PIK3R3 FREM2 PTPN13 HOXC6 TENM4 HMCN1 TENM3 PIK3R1 KRT20 PPIP5K2 PATJ RIOK2 CDH6 CDH11 | 8.18e-05 | 797 | 156 | 17 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CPA6 PPP1R12A FAT3 HIPK2 MSI1 KANK2 TENM4 HMCN1 PRICKLE2 PLEKHA5 RBM24 PATJ CAPRIN1 CDH11 RBFOX2 FOXC1 SORL1 | 9.37e-05 | 806 | 156 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#5_top-relative-expression-ranked_200 | 9.72e-05 | 33 | 156 | 4 | gudmap_developingKidney_e15.5_200_k5 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_200 | 1.05e-04 | 13 | 156 | 3 | gudmap_kidney_P2_CapMes_Crym_k1_200 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_200 | 1.05e-04 | 13 | 156 | 3 | gudmap_kidney_P1_CapMes_Crym_k1_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.14e-04 | 148 | 156 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#4_top-relative-expression-ranked_500 | 1.25e-04 | 66 | 156 | 5 | gudmap_developingKidney_e15.5_500_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | FLNA USP11 FAT3 TRPC6 SLITRK2 PTPN13 HOXC6 TENM4 PTPRD HMCN1 TENM3 PIK3R1 LOXL1 SCN2A CDH6 CDH11 FOXC2 | 1.28e-04 | 827 | 156 | 17 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_200 | 1.51e-04 | 155 | 156 | 7 | gudmap_developingKidney_e15.5_anlage of loop of Henle_200 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_100 | 2.03e-04 | 16 | 156 | 3 | gudmap_kidney_adult_CortVasc_Tie2_k4_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 2.22e-04 | 165 | 156 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | ARHGAP32 FN1 DSC3 HLA-DQA1 PTPN13 CIITA SYNJ2 PTPRQ KRT20 STRA6 IL4I1 | 2.37e-04 | 411 | 156 | 11 | GSM854302_500 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_200 | 2.62e-04 | 120 | 156 | 6 | gudmap_kidney_P1_CapMes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | FLNA FAT3 TRPC6 PTPN13 HOXC6 TENM4 HMCN1 TENM3 SCN2A CDH6 CDH11 | 2.73e-04 | 418 | 156 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 2.86e-04 | 122 | 156 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PRSS12 PSG9 TRPC6 HOXC6 PTPRQ PSG8 | 3.00e-04 | 494 | 156 | 12 | JC_fibro_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | FLNA USP11 FAT3 TRPC6 HOXC6 TENM4 TENM3 PIK3R1 CDH6 CDH11 FOXC2 | 3.02e-04 | 423 | 156 | 11 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 3.55e-04 | 127 | 156 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 4.03e-04 | 130 | 156 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 4.09e-04 | 240 | 156 | 8 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.10e-04 | 85 | 156 | 5 | gudmap_kidney_P0_CapMes_Crym_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.55e-04 | 133 | 156 | 6 | gudmap_developingKidney_e15.5_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.73e-04 | 134 | 156 | 6 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | HLA-DQA1 ADCY8 PIEZO2 SLC8B1 KCNA6 OSBPL6 PRICKLE2 EMP2 FXYD2 FOXC1 CDH18 MIA | 5.61e-04 | 530 | 156 | 12 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2 | FN1 HLA-DQA1 MSI1 PTPN13 CIITA SYNJ2 PTPRQ KRT20 STRA6 IL4I1 | 5.63e-04 | 384 | 156 | 10 | GSM777041_500 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_200 | 5.74e-04 | 139 | 156 | 6 | gudmap_kidney_P2_CapMes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | FLNA FN1 USP11 FAT3 TRPC6 SLITRK2 PIEZO2 HOXC6 TENM4 HMCN1 TENM3 LOXL1 SCN2A LTBP4 CDH11 | 5.90e-04 | 773 | 156 | 15 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FLNA FN1 FAT3 TRPC6 SLITRK2 PIEZO2 HOXC6 TENM4 PTPRD HMCN1 TENM3 LOXL1 LTBP4 CDH6 CDH11 | 6.22e-04 | 777 | 156 | 15 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | FN1 PSG1 PSG2 PSG4 PRSS12 CNTNAP1 KANK2 HOXC6 PTPRM PSG8 CDH11 | 6.55e-04 | 464 | 156 | 11 | JC_fibro_1000_K1 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | FLNA FAT3 TRPC6 PTPN13 HOXC6 TENM4 PTPRD PTPRF HMCN1 TENM3 PIK3R1 SCN2A PPIP5K2 CDH6 CDH11 | 6.72e-04 | 783 | 156 | 15 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.19e-04 | 327 | 156 | 9 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_1000 | ARHGAP32 HLA-DQA1 ASAH2 TRPC6 PSMB8 PSMB9 LARP1B CLOCK PIEZO2 HOXC6 PTPRM PIK3R1 LPIN2 SMPD1 FOXC1 FOXC2 | 7.59e-04 | 878 | 156 | 16 | gudmap_kidney_adult_RenCorpuscGlomer_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | PRSS12 HLA-DQA1 FAT3 PSMB9 GSC ADCY8 NLGN3 PTPRD LOXL1 PRICKLE2 DLX5 EMP2 SMOX FXYD2 LTBP4 FOXC1 MIA | 7.73e-04 | 967 | 156 | 17 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | PPP1R12A HIPK2 RBMX SKAP1 OSBPL6 PKHD1 NCOA7 PLEKHA5 PATJ FXYD2 CAPRIN1 CDH6 RBFOX2 FOXC1 SORL1 | 7.85e-04 | 795 | 156 | 15 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_1000 | FAT3 MSI1 LYST HOXC6 HMCN1 TENM3 PTPRM SCN2A LPIN2 SMOX CDH11 FOXC1 FOXC2 | 8.22e-04 | 633 | 156 | 13 | gudmap_kidney_P1_CapMes_Crym_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 8.41e-04 | 206 | 156 | 7 | JC_fibro_500_K3 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_1000 | FAT3 MSI1 LYST FREM2 HOXC6 HMCN1 TENM3 PTPRM LPIN2 SMOX CDH6 CDH11 FOXC2 | 8.59e-04 | 636 | 156 | 13 | gudmap_kidney_P2_CapMes_Crym_1000 |
| CoexpressionAtlas | B cells, B.MZ.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21.35+, Spleen, avg-1 | 8.74e-04 | 58 | 156 | 4 | GSM538210_100 | |
| CoexpressionAtlas | B cells, B.MZ.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21/35+, Spleen, avg-2 | 8.74e-04 | 58 | 156 | 4 | GSM538211_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | CPA6 PPP1R12A HIPK2 OSBPL6 PRICKLE2 PLEKHA5 FXYD2 CDH11 RBFOX2 FOXC2 | 9.64e-04 | 412 | 156 | 10 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_500 | FAT3 LARP1B FREM2 PTPN13 PIEZO2 FXYD2 CDH6 CDH11 FOXC1 FOXC2 | 9.64e-04 | 412 | 156 | 10 | gudmap_kidney_e15.5_Podocyte_MafB_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 9.85e-04 | 103 | 156 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.05e-03 | 156 | 156 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 1.11e-03 | 28 | 156 | 3 | gudmap_kidney_P2_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | ZNF703 FN1 PSG5 HOXC6 KCNA2 TENM4 HMCN1 LOXL1 SMPD1 DLX5 PAX5 STRA6 CDH6 CDH11 FOXC1 CDH18 MIA FOXC2 | 1.15e-03 | 1094 | 156 | 18 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_200 | 1.20e-03 | 160 | 156 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | FLNA USP11 FAT3 TRPC6 SLITRK2 PTPN13 HOXC6 TENM4 HMCN1 TENM3 PIK3R1 SCN2A CDH6 CDH11 FOXC2 | 1.22e-03 | 831 | 156 | 15 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1F FAT3 PKHD1L1 FREM2 MELTF SLITRK2 PIEZO2 TENM4 KCNA4 PTPRD HMCN1 SCN2A PTPRQ PKHD1 EPHA10 | 2.04e-16 | 184 | 159 | 15 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1F FAT3 PKHD1L1 FREM2 MELTF SLITRK2 PIEZO2 TENM4 KCNA4 PTPRD HMCN1 SCN2A PTPRQ PKHD1 EPHA10 | 2.04e-16 | 184 | 159 | 15 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1F FAT3 PKHD1L1 FREM2 MELTF SLITRK2 PIEZO2 TENM4 KCNA4 PTPRD HMCN1 SCN2A PTPRQ PKHD1 EPHA10 | 2.04e-16 | 184 | 159 | 15 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.63e-11 | 136 | 159 | 10 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-10 | 194 | 159 | 11 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | FN1 FAT3 HOXC6 TENM4 PTPRD TENM3 DLX5 EMP2 CDH11 RBFOX2 FOXC2 | 1.65e-10 | 200 | 159 | 11 | 3c898e81444b001835c3f1bbc68183078701b135 |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | FN1 FAT3 HOXC6 TENM4 PTPRD TENM3 DLX5 EMP2 CDH11 RBFOX2 FOXC2 | 1.65e-10 | 200 | 159 | 11 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.62e-09 | 198 | 159 | 10 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-08 | 188 | 159 | 9 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 3.05e-08 | 191 | 159 | 9 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.33e-08 | 193 | 159 | 9 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.33e-08 | 193 | 159 | 9 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.33e-08 | 193 | 159 | 9 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.33e-08 | 193 | 159 | 9 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.33e-08 | 193 | 159 | 9 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-08 | 195 | 159 | 9 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.64e-08 | 195 | 159 | 9 | 30ed961151b8b1f6ce37f06c9a061519f01c2864 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.64e-08 | 195 | 159 | 9 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.81e-08 | 196 | 159 | 9 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.81e-08 | 196 | 159 | 9 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-08 | 197 | 159 | 9 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-08 | 197 | 159 | 9 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.98e-08 | 197 | 159 | 9 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-08 | 197 | 159 | 9 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.98e-08 | 197 | 159 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.15e-08 | 198 | 159 | 9 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.15e-08 | 198 | 159 | 9 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.15e-08 | 198 | 159 | 9 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.34e-08 | 199 | 159 | 9 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 4.53e-08 | 200 | 159 | 9 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.53e-08 | 200 | 159 | 9 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.53e-08 | 200 | 159 | 9 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.53e-08 | 200 | 159 | 9 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.53e-07 | 166 | 159 | 8 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-07 | 175 | 159 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.40e-07 | 176 | 159 | 8 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.40e-07 | 176 | 159 | 8 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-07 | 178 | 159 | 8 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-07 | 183 | 159 | 8 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.50e-07 | 185 | 159 | 8 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.65e-07 | 186 | 159 | 8 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.96e-07 | 188 | 159 | 8 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.29e-07 | 190 | 159 | 8 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.47e-07 | 191 | 159 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-07 | 192 | 159 | 8 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-07 | 192 | 159 | 8 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.65e-07 | 192 | 159 | 8 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.83e-07 | 193 | 159 | 8 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | metastatic_Lymph_Node|World / Location, Cell class and cell subclass | 5.03e-07 | 194 | 159 | 8 | af6b5806238a610443564754367e91ce378c4a6d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.03e-07 | 194 | 159 | 8 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 5.22e-07 | 195 | 159 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.22e-07 | 195 | 159 | 8 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.22e-07 | 195 | 159 | 8 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-07 | 195 | 159 | 8 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.43e-07 | 196 | 159 | 8 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.43e-07 | 196 | 159 | 8 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.43e-07 | 196 | 159 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.43e-07 | 196 | 159 | 8 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.43e-07 | 196 | 159 | 8 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.43e-07 | 196 | 159 | 8 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-07 | 196 | 159 | 8 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.64e-07 | 197 | 159 | 8 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.64e-07 | 197 | 159 | 8 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.64e-07 | 197 | 159 | 8 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.64e-07 | 197 | 159 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 5.64e-07 | 197 | 159 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.86e-07 | 198 | 159 | 8 | 60d8d3bbd754ffde41c50013d822667b185a9751 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.86e-07 | 198 | 159 | 8 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.09e-07 | 199 | 159 | 8 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 6.09e-07 | 199 | 159 | 8 | 95403988caef322314f4ed15415ad1a9a987adc1 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.09e-07 | 199 | 159 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.09e-07 | 199 | 159 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.09e-07 | 199 | 159 | 8 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.09e-07 | 199 | 159 | 8 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.09e-07 | 199 | 159 | 8 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.09e-07 | 199 | 159 | 8 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.09e-07 | 199 | 159 | 8 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.33e-07 | 200 | 159 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Alveolar_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.33e-07 | 200 | 159 | 8 | 0ed49c2177b58269ff7653db6be7d68633a5d34a | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-07 | 200 | 159 | 8 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.33e-07 | 200 | 159 | 8 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.21e-06 | 151 | 159 | 7 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Oncocytic_Type-6|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.70e-06 | 101 | 159 | 6 | b9df110a4dbd44d5e36a21ff976ffe5ef4e1c1c5 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Oncocytic_Type|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.70e-06 | 101 | 159 | 6 | 715d1c0192b9f397f285fe695950ca030af3233f | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 160 | 159 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 160 | 159 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.86e-06 | 161 | 159 | 7 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.11e-06 | 164 | 159 | 7 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-06 | 165 | 159 | 7 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-06 | 165 | 159 | 7 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-06 | 167 | 159 | 7 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.95e-06 | 111 | 159 | 6 | 1847dde68d349114286bc3317be6339666df4aa2 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 173 | 159 | 7 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 173 | 159 | 7 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.00e-06 | 173 | 159 | 7 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-06 | 174 | 159 | 7 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.24e-06 | 175 | 159 | 7 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.24e-06 | 175 | 159 | 7 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.24e-06 | 175 | 159 | 7 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 176 | 159 | 7 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| Computational | Neighborhood of EGFR | 7.41e-10 | 32 | 109 | 8 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 1.62e-09 | 35 | 109 | 8 | GNF2_IGFBP1 | |
| Computational | Neighborhood of CDKN1C | 6.82e-09 | 27 | 109 | 7 | GNF2_CDKN1C | |
| Computational | Neighborhood of MMP11 | 7.65e-09 | 42 | 109 | 8 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.63e-08 | 46 | 109 | 8 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.76e-08 | 49 | 109 | 8 | GNF2_KISS1 | |
| Computational | Porins / transporters. | 2.85e-04 | 211 | 109 | 9 | MODULE_63 | |
| Computational | Genes in the cancer module 424. | 7.41e-04 | 18 | 109 | 3 | MODULE_424 | |
| Drug | AC1L1IPV | 3.06e-13 | 43 | 158 | 10 | CID000004683 | |
| Drug | Psora-4 | 1.67e-10 | 13 | 158 | 6 | CID006603977 | |
| Drug | pP-8 | 3.70e-09 | 10 | 158 | 5 | CID000444681 | |
| Drug | Rgd Peptide | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 LAMC3 PTPRM PSG8 | 1.31e-08 | 239 | 158 | 13 | CID000104802 |
| Drug | CID10948590 | 3.31e-08 | 6 | 158 | 4 | CID010948590 | |
| Drug | pyraclofos | 5.49e-08 | 106 | 158 | 9 | CID000093460 | |
| Drug | AC1L1B9H | 6.99e-08 | 78 | 158 | 8 | CID000001341 | |
| Drug | tetrapentylammonium | 8.74e-08 | 17 | 158 | 5 | CID000017248 | |
| Drug | LY97241 | 2.74e-07 | 9 | 158 | 4 | CID000175064 | |
| Drug | clofilium | 8.27e-07 | 74 | 158 | 7 | CID000002798 | |
| Drug | digitoxigenine | 1.41e-06 | 51 | 158 | 6 | CID000008932 | |
| Drug | potassium | CACNA1F FN1 PIK3R3 GALR2 ADCY8 CHRNB3 KCNA1 SLC8B1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SACS PIK3R1 SCN2A SMPD1 EMP2 BSN FXYD2 RBFOX2 | 1.91e-06 | 1008 | 158 | 22 | CID000000813 |
| Drug | reduced haloperidol | 5.50e-06 | 37 | 158 | 5 | CID000119265 | |
| Drug | AC1NPPZW | 7.69e-06 | 103 | 158 | 7 | CID005183170 | |
| Drug | acetazolamide | 9.89e-06 | 107 | 158 | 7 | CID000001986 | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.00e-05 | 197 | 158 | 9 | 2241_UP | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Up 200; 9.6uM; HL60; HG-U133A | 1.09e-05 | 199 | 158 | 9 | 1623_UP | |
| Drug | AC1Q646P | 1.83e-05 | 47 | 158 | 5 | CID000005673 | |
| Drug | doyle | 3.44e-05 | 88 | 158 | 6 | CID000002245 | |
| Drug | E 4031 | 3.63e-05 | 54 | 158 | 5 | CID000003184 | |
| Disease | cD177 antigen measurement | 1.55e-14 | 18 | 150 | 8 | EFO_0021866 | |
| Disease | epilepsy (implicated_via_orthology) | KCNA1 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 SCN2A PRICKLE2 BSN | 1.21e-08 | 163 | 150 | 10 | DOID:1826 (implicated_via_orthology) |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 2.55e-06 | 6 | 150 | 3 | EFO_0801907 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 4.44e-06 | 7 | 150 | 3 | EFO_0801906 | |
| Disease | visual perception measurement | 1.97e-05 | 223 | 150 | 8 | EFO_0009700 | |
| Disease | smoking status measurement, forced expiratory volume | 2.06e-05 | 11 | 150 | 3 | EFO_0004314, EFO_0006527 | |
| Disease | Acute tubulointerstitial nephritis | 2.57e-05 | 2 | 150 | 2 | HP_0004729 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 3 in blood serum | 2.57e-05 | 2 | 150 | 2 | OBA_2043058 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 4 in blood serum | 2.57e-05 | 2 | 150 | 2 | OBA_2043059 | |
| Disease | level of intelectin-1 in blood serum | 2.57e-05 | 2 | 150 | 2 | OBA_2044678 | |
| Disease | Nakajo syndrome | 2.57e-05 | 2 | 150 | 2 | C1850568 | |
| Disease | exfoliation syndrome (implicated_via_orthology) | 2.57e-05 | 2 | 150 | 2 | DOID:13641 (implicated_via_orthology) | |
| Disease | nasopharyngeal neoplasm | 1.27e-04 | 151 | 150 | 6 | EFO_0004252 | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 1.53e-04 | 4 | 150 | 2 | EFO_0801909 | |
| Disease | sperm acrosome membrane-associated protein 3 measurement | 1.53e-04 | 4 | 150 | 2 | EFO_0802081 | |
| Disease | gestational diabetes | 2.12e-04 | 23 | 150 | 3 | EFO_0004593 | |
| Disease | chronic fatigue syndrome (is_implicated_in) | 2.54e-04 | 5 | 150 | 2 | DOID:8544 (is_implicated_in) | |
| Disease | L lactate dehydrogenase measurement | 3.07e-04 | 26 | 150 | 3 | EFO_0004808 | |
| Disease | hearing loss | 3.83e-04 | 67 | 150 | 4 | EFO_0004238 | |
| Disease | obsolete_red blood cell distribution width | ARHGAP23 PSG1 ASAH2 CR1L KANK2 CHRNB3 CYFIP1 KCNA4 PIK3R1 G3BP2 EIF3L LPIN2 TMC8 RBM6 SMOX RBFOX2 CDH18 | 5.14e-04 | 1347 | 150 | 17 | EFO_0005192 |
| Disease | tumor necrosis factor receptor superfamily member 6 measurement | 5.30e-04 | 7 | 150 | 2 | EFO_0010610 | |
| Disease | panic disorder | 6.28e-04 | 33 | 150 | 3 | EFO_0004262 | |
| Disease | exfoliation syndrome (is_marker_for) | 7.04e-04 | 8 | 150 | 2 | DOID:13641 (is_marker_for) | |
| Disease | Microphthalmia associated with colobomatous cyst | 7.04e-04 | 8 | 150 | 2 | C2931501 | |
| Disease | Gastrointestinal Hemorrhage | 9.03e-04 | 9 | 150 | 2 | C0017181 | |
| Disease | head and neck malignant neoplasia | 9.03e-04 | 9 | 150 | 2 | EFO_0006859 | |
| Disease | reticulocyte measurement | FLNA PSG1 HLA-DQA1 KANK2 ADCY8 SBNO2 KCNA4 PIK3R1 LPIN2 TMC8 RBM6 NCOA7 BSN SMOX | 9.95e-04 | 1053 | 150 | 14 | EFO_0010700 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.10e-03 | 152 | 150 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cocaine use | 1.37e-03 | 11 | 150 | 2 | C3496069 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 1.37e-03 | 11 | 150 | 2 | EFO_0008209 | |
| Disease | melanoma-derived growth regulatory protein measurement | 1.37e-03 | 11 | 150 | 2 | EFO_0008229 | |
| Disease | endometrial carcinoma, endometriosis | 1.37e-03 | 11 | 150 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | susceptibility to pneumonia measurement | 1.54e-03 | 97 | 150 | 4 | EFO_0008410 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 1.64e-03 | 12 | 150 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | cortical thickness | B4GALNT1 PSG1 PRSS12 FAT3 LAMC3 CLOCK NHSL1 KCNA5 PTPRF PIK3R1 PKHD1 DLX5 CDH11 FOXC2 | 1.67e-03 | 1113 | 150 | 14 | EFO_0004840 |
| Disease | ulcerative colitis | 1.68e-03 | 335 | 150 | 7 | EFO_0000729 | |
| Disease | major depressive episode | 1.77e-03 | 47 | 150 | 3 | EFO_0007634 | |
| Disease | endometriosis | 1.88e-03 | 252 | 150 | 6 | EFO_0001065 | |
| Disease | juvenile rheumatoid arthritis (is_implicated_in) | 1.93e-03 | 13 | 150 | 2 | DOID:676 (is_implicated_in) | |
| Disease | granulocyte count | 1.95e-03 | 254 | 150 | 6 | EFO_0007987 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 2.00e-03 | 49 | 150 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | erythrocyte measurement | 2.07e-03 | 257 | 150 | 6 | EFO_0005047 | |
| Disease | inflammatory bowel disease | 2.17e-03 | 449 | 150 | 8 | EFO_0003767 | |
| Disease | tonsillectomy risk measurement | 2.20e-03 | 260 | 150 | 6 | EFO_0007924 | |
| Disease | Oral ulcer | 2.21e-03 | 107 | 150 | 4 | HP_0000155 | |
| Disease | oral cavity cancer | 2.24e-03 | 14 | 150 | 2 | EFO_0005570 | |
| Disease | complement factor H measurement, protein binding measurement | 2.24e-03 | 14 | 150 | 2 | EFO_0008097, EFO_0010742 | |
| Disease | C-C motif chemokine 19 measurement | 2.24e-03 | 14 | 150 | 2 | EFO_0008047 | |
| Disease | cerebellum cortex volume change measurement | 2.24e-03 | 14 | 150 | 2 | EFO_0021497 | |
| Disease | interleukin 12 measurement | 2.50e-03 | 53 | 150 | 3 | EFO_0004753 | |
| Disease | human papilloma virus infection, oropharynx cancer | 2.50e-03 | 53 | 150 | 3 | EFO_0001668, EFO_1001931 | |
| Disease | Yu-Zhi constitution type | 2.58e-03 | 15 | 150 | 2 | EFO_0007638 | |
| Disease | mean reticulocyte volume | PSG1 HLA-DQA1 SBNO2 KCNA4 PTPRF PIK3R1 LPIN2 RBM6 SMOX MAP2K2 CDH6 | 2.65e-03 | 799 | 150 | 11 | EFO_0010701 |
| Disease | Cardiovascular Abnormalities | 2.94e-03 | 16 | 150 | 2 | C0243050 | |
| Disease | Tetralogy of Fallot | 2.94e-03 | 16 | 150 | 2 | C0039685 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.94e-03 | 16 | 150 | 2 | C0393706 | |
| Disease | IGA glomerulonephritis | 3.24e-03 | 58 | 150 | 3 | EFO_0004194 | |
| Disease | ferritin measurement | 3.24e-03 | 119 | 150 | 4 | EFO_0004459 | |
| Disease | SLAM family member 7 measurement | 3.32e-03 | 17 | 150 | 2 | EFO_0008287 | |
| Disease | Huntington Disease | 3.32e-03 | 17 | 150 | 2 | C0020179 | |
| Disease | serum albumin measurement | 3.38e-03 | 592 | 150 | 9 | EFO_0004535 | |
| Disease | Malignant neoplasm of breast | FLNA FN1 DSC3 MSI1 RFX2 FAAH FASN PTPRD KCNA5 SYNJ2 G3BP2 SMOX SORL1 | 3.39e-03 | 1074 | 150 | 13 | C0006142 |
| Disease | androstenedione measurement, estrone measurement | 3.72e-03 | 18 | 150 | 2 | EFO_0007970, EFO_0007972 | |
| Disease | Child Behaviour Checklist assessment | 3.72e-03 | 18 | 150 | 2 | EFO_0005661 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.72e-03 | 18 | 150 | 2 | HP_0002373 | |
| Disease | tropical spastic paraparesis | 3.72e-03 | 18 | 150 | 2 | EFO_0007527 | |
| Disease | eosinophil count | FLNA DNAH3 PSG1 HLA-DQA1 PSMB9 RFX6 FAAH SBNO2 MELTF CIITA POLR1B LTF MAP2K2 LTBP4 MUC5AC EPHA10 | 3.82e-03 | 1488 | 150 | 16 | EFO_0004842 |
| Disease | diet measurement, HOMA-B | 4.15e-03 | 19 | 150 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 4.15e-03 | 19 | 150 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | angiopoietin-1 receptor measurement | 4.15e-03 | 19 | 150 | 2 | EFO_0010600 | |
| Disease | rheumatoid arthritis, COVID-19 | 4.28e-03 | 64 | 150 | 3 | EFO_0000685, MONDO_0100096 | |
| Disease | vital capacity | FN1 HLA-DQA1 ADCY8 MELTF HOXC6 PTPRD HMCN1 PIK3R1 LOXL1 SKAP1 OSBPL6 PATJ SMOX LTBP4 | 4.30e-03 | 1236 | 150 | 14 | EFO_0004312 |
| Disease | exercise test | 4.59e-03 | 20 | 150 | 2 | EFO_0004328 | |
| Disease | Autoimmune Hepatitis | 5.06e-03 | 21 | 150 | 2 | EFO_0005676 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 5.06e-03 | 21 | 150 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | vitiligo (is_implicated_in) | 5.06e-03 | 21 | 150 | 2 | DOID:12306 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RYNVYGYTGQGVFSN | 686 | Q13523 | |
| PSNSDFFLNGGYSYR | 136 | P40145 | |
| YLYRYPGGESYQDLV | 356 | O60825 | |
| GNRRDGVYSYPFITY | 211 | Q05901 | |
| GPLYARSLGASSYYS | 31 | P78357 | |
| AGAETYARYRYPGSL | 496 | Q00973 | |
| FYRSLQDTYGAEPAG | 341 | P33076 | |
| SATTYIGLNPGYRVY | 486 | P17405 | |
| GYRVYQIDGNYSGSS | 496 | P17405 | |
| DRGPSSYYNVEYAVG | 236 | Q15782 | |
| YRYGPASTTLYVSSG | 366 | Q8N4T0 | |
| YTQSQFSAPRDYSGY | 651 | Q14444 | |
| FSAPRDYSGYQRDGY | 656 | Q14444 | |
| YHQYGGAYNRVPSAT | 101 | P56178 | |
| VASYGVNLYQSYGPS | 31 | P01909 | |
| NSPYIVGFYGAFYSD | 126 | P36507 | |
| TTPYIDYTGAAYAQY | 146 | Q9BX46 | |
| YGHSSSRDDYPSRGY | 246 | P38159 | |
| YRDSYESYGNSRSAP | 281 | P38159 | |
| YYGSNINYPESHRLG | 801 | Q8HWS3 | |
| LYGGYAAYRYAQPAT | 321 | O43251 | |
| SSYINANYIRGYGGE | 351 | P54829 | |
| YAYGVMDSGYRPNLS | 206 | P28062 | |
| LGSPYYYSAAARGAA | 366 | Q02548 | |
| YGLGPSAYVSSFFNR | 581 | O60840 | |
| LAYSSIYGSYRNFVG | 896 | Q7L576 | |
| YGNSTRSYAVRVGDY | 681 | P56730 | |
| SYYSPYGQREFTAGF | 221 | Q8WWA0 | |
| NRPSFDAILYYYQSG | 81 | P16389 | |
| GTFRCYGYENNTPYV | 191 | P59901 | |
| GTYRCYGSRSSNPYL | 391 | P59901 | |
| RPSFDAILYYYQSGG | 86 | Q09470 | |
| YPGASEYDQIRYISQ | 401 | Q9H2X6 | |
| GGPSLEQRFESYYNY | 146 | Q9Y262 | |
| YQAQRYEAASTIYGP | 586 | Q9NR71 | |
| PGNVGEFTAYRILYY | 656 | Q96PV6 | |
| IGETYPYQYSLSIRG | 2606 | Q5SZK8 | |
| RTYDQGFVYYRPAGG | 196 | Q08397 | |
| NGRPASTHYYGDSDY | 3311 | Q9UPA5 | |
| DGYRSSQYYSQGPTF | 126 | Q5SYE7 | |
| YYGAGLFMYIRPTSD | 251 | A3KFT3 | |
| AAEGGYQRYGVRSYL | 16 | Q8IZ57 | |
| FDAILYYYQSGGRIR | 156 | P22001 | |
| AGTYRCYGSLNSDPY | 391 | Q8N423 | |
| YYGRVRAASAGSYSE | 131 | Q969J5 | |
| DSAGRYRCYYETPAG | 91 | O75023 | |
| VPYLSEQNYYRAAGS | 16 | Q99958 | |
| CVYNGAAYAPGATYS | 396 | P98088 | |
| GAPGANDTEYEIRYY | 481 | Q5JZY3 | |
| STFIYGYVDAAYKPG | 151 | P28065 | |
| LYYTPVSNYGDGDIY | 636 | Q6IE36 | |
| YGIPYSYTAYGSSDA | 351 | Q9Y5B6 | |
| ATGYGFAEPYNLYSS | 676 | P27986 | |
| FENGRVHYRYSPYSS | 1641 | A7KAX9 | |
| YETNAPRAGRDYSAY | 106 | P35900 | |
| TYASRSYTGLAPGYT | 226 | O43347 | |
| GSMPTNYELYYGFTR | 816 | Q9BZF3 | |
| GLERLPNYGTQYSSY | 5356 | Q96RW7 | |
| PNYGTQYSSYNLARF | 5361 | Q96RW7 | |
| PGSDYINASYISGYL | 2086 | Q9UMZ3 | |
| SRGPYDYGSNSFYQE | 66 | P09630 | |
| FPERIYQGSSGSYFV | 126 | Q9BTU6 | |
| DYYPGRLRSQESYSD | 471 | Q7Z3G6 | |
| YSVSNFVDNLYGYPE | 431 | Q9NZ94 | |
| ADLHARYGSPTYFYA | 491 | Q9NZ94 | |
| IYSTARGYGFAEPYN | 406 | Q92569 | |
| RGYGFAEPYNLYSSL | 411 | Q92569 | |
| FSGPYLSYYRQSQLA | 156 | O43603 | |
| YPVTREGSYGYSYIL | 131 | P54851 | |
| SFDGILYYYQSGGRL | 171 | P22460 | |
| PSFDAILYYYQSGGR | 91 | P17658 | |
| HRPSFDAVLYYYQSG | 61 | Q96RP8 | |
| QDYVLTYNYEGRGSP | 846 | Q14574 | |
| TTEALYGYEYLGNSP | 1386 | Q8TD57 | |
| PYEAGTYSLNVTYGG | 1416 | P21333 | |
| YTGNTYRVGDTYERP | 101 | P02751 | |
| VPYLGGEQSYYRAAA | 16 | Q12948 | |
| APEYLHRFYGRNSSY | 26 | Q9UN86 | |
| YSCEPGYDLRGSTYL | 316 | Q2VPA4 | |
| NGYIRYSLYGSGNSE | 3061 | Q8TDW7 | |
| YYIRYRGAVYADSGN | 391 | Q9BSK4 | |
| PYDSIQIYGYEGRGS | 736 | P55287 | |
| NYRGCEYSYGPAFTR | 81 | Q9NQ33 | |
| EETGRFYYTTPNSYL | 2221 | Q0VDD8 | |
| YYQGRPDFLSYRHAS | 551 | Q8IY82 | |
| FAYSLGYEPNYNRTA | 2276 | Q99698 | |
| AGPGYHYSASDLRYN | 461 | Q8N2S1 | |
| TASYYSPYGQREFVA | 231 | Q8WWU7 | |
| PYDSLQTYAYEGQRS | 731 | Q13634 | |
| TNYGEEGSAYSLLYP | 741 | Q8N7U6 | |
| SYCGRGFYPQYGALE | 101 | Q63ZY3 | |
| AAVSGSRLGYNNYFY | 71 | P56915 | |
| YNGCGAFGYRRYSPF | 46 | Q8IUC2 | |
| GDYLRYPASSRGFSY | 16 | Q52LG2 | |
| SYGSRFCYPNYLASG | 126 | Q3LI77 | |
| VDPFYYDYETVRNGG | 16 | P54710 | |
| PYDSLATYAYEGTGS | 731 | P55285 | |
| SSQPLRVGYYETDNY | 321 | O00519 | |
| PYRVAGYSYGACVAF | 2301 | P49327 | |
| NGELLYGSPATTAYY | 466 | Q9H4Q3 | |
| YGPAYSGRERVYSNA | 91 | Q00888 | |
| SIYPSFTYYRSGENL | 336 | Q00888 | |
| YGPAYSGRETVYSNA | 91 | Q9UQ72 | |
| GDIYGSYQPTYTYAI | 4191 | Q9NZJ4 | |
| YGPAYSGRETAYSNA | 91 | P11464 | |
| PRLNFDYSYGYQEHG | 166 | Q659C4 | |
| YGDYQPEVHGVSYFR | 711 | Q12923 | |
| SGNSEPVTYYGIQYR | 341 | P10586 | |
| PVTYYGIQYRAAGTE | 346 | P10586 | |
| NGLVRGYRVYYTPDS | 441 | P10586 | |
| PGSDYINANYIDGYR | 1401 | P10586 | |
| SDYINGNYIDGYHRP | 951 | P28827 | |
| YGPAYSGRETVYSNA | 91 | Q16557 | |
| PGSDYVNANYIDGYR | 1406 | P23468 | |
| NTNSYDYGDEYRPLF | 281 | Q6J4K2 | |
| VPYGRIYFAGEHTAY | 471 | Q96RQ9 | |
| DYYGDLAARLGYFPS | 91 | Q16674 | |
| IYDSATGYYYDPLAG | 791 | P78332 | |
| YYSPGGAGSDTLVRY | 391 | Q92673 | |
| YGHSSSRDDYPSRGY | 246 | Q96E39 | |
| YRDSYESYGNSRSAP | 281 | Q96E39 | |
| AGGSRYYLAYGSITP | 71 | O75920 | |
| CVPNSNERYYGYTGA | 536 | P02788 | |
| VGNSQERYYGYRGAF | 546 | P08582 | |
| FGPTYKYDVGSAAYD | 776 | O15056 | |
| TGRCQFYSSGVGYLY | 121 | Q8WV15 | |
| HYYGTGETFLYTFSP | 856 | Q8NI08 | |
| VYTNGAIRTAYTYNP | 81 | P48378 | |
| IYPSFTYYRSGENLD | 336 | Q00889 | |
| YGPAYSGRETIYSNA | 91 | Q9UQ74 | |
| YGPAYSGRETVYSNA | 91 | Q00887 | |
| RIYPSFTYYRSGENL | 336 | Q00887 | |
| PDVGYNGYTREAYFS | 376 | Q5JRX3 | |
| GDPVAYYRNLQEFSY | 706 | Q9H156 | |
| TGPYDGFYLSYKVRG | 1061 | Q9Y2G9 | |
| YSYGYNGLGYNRLRV | 96 | Q92968 | |
| GPHYLSVFYTRNGYA | 1546 | P08F94 | |
| YGPAYSGRETVYSNA | 91 | Q13046 | |
| YNYSLRPSGSYEFGT | 516 | Q5JTZ9 | |
| AATLDPGYYTYRNFL | 556 | Q9BX79 | |
| YSALFLGVAYGATRY | 16 | P56385 | |
| GYRTGYTYRHPFVQE | 376 | P35612 | |
| PFEVLGTSGYDYYHV | 301 | O15516 | |
| GYPGAERNLLEYSYF | 16 | Q8NE65 | |
| YSPYALYGQRLASAS | 571 | Q9H7S9 | |
| NTYLFYGAYRVGPES | 181 | Q8IU68 | |
| YGAYRVGPESSSVYS | 186 | Q8IU68 | |
| TGRTVYSQEAQPYGY | 926 | Q8NI35 | |
| LDDLGYIGYRSYSPS | 411 | Q9P227 | |
| AGRNPNYGYTSFDTF | 356 | Q99250 | |
| PYFRGSYSYTQVGSS | 476 | Q9NWM0 | |
| VYFGLSAYQIRCGYP | 2301 | Q9H5I5 | |
| ETTYYQTALPGNDRY | 66 | Q9UHP3 | |
| LPTGDYLYNFTYTGD | 1601 | Q6N022 | |
| YQIGYDGSLRIIYAS | 1696 | Q9P273 | |
| FTSPGIHYYSSGYVD | 1471 | Q86WI1 | |
| AASYGQGGYLYRELY | 681 | Q9BWH6 | |
| QGYRLTNAGYDYLAL | 71 | Q9BVS4 | |
| ENGSGAPYVYHAIYL | 456 | Q9NZI7 | |
| PYEYIVSGDSLNYGS | 241 | Q6NX49 | |
| YGPAYSGRETAYSNA | 91 | P11465 | |
| PSYTNYRSGDNLYLS | 246 | P11465 | |
| GYGIDAYGYRQTYSL | 781 | Q9C0D7 | |
| AYGYRQTYSLPDNST | 786 | Q9C0D7 | |
| YGYYPCFRGSDNRLA | 51 | Q9Y210 | |
| VYIYYPTSAGGGSQR | 196 | O43314 | |
| YNFYGTERLYSGISG | 971 | Q9H9Y6 | |
| AAYQGYSPQRTYRSE | 551 | Q9HAU0 | |
| YGPAYTGRETVYSNA | 91 | Q15238 | |
| PSFTYYRSGENLYLS | 246 | Q15238 | |
| ERTPARDYNNSYYGL | 596 | P51784 | |
| SGTRRKGVDYASYYQ | 286 | Q86WV1 | |
| PSFDAILYYYQSGGR | 226 | P22459 | |
| RLYAVGGYDGQTYLN | 701 | Q9NR64 | |
| QSYYYAVSDFSVGGR | 256 | Q9Y6N6 | |
| YAAFGNRPNDVYAYT | 806 | Q92539 | |
| GRSGSYSYLEERKPY | 906 | O14974 |